Zusammenfassung
Das Spektrum der organischen psychischen Störungen umfasst eine Vielzahl von verschiedenen Störungen. Diese werden in den folgenden Kapiteln eingehend dargestellt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Literatur
Ahmed S, Bierley R, Sheikh JI, Date ES (2000) Post-traumatic amnesia after closed head injury: a review of the literature and some suggestions for further research. Brain Inj 14:765–780
Albert MS, Butters N, Levin J (1979) Temporal gradients in the retrograde amnesia of patients with alcoholic Korsakoff’s disease. Arch Neurol 36:211–216
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM IV). American Psychiatric Association, Washington DC, S 123–163
Baddeley AD, Warrington EK (1970) Amnesia and the distinction between long-and short-term memory. J Verbal Learning and Verbal Behavior 9:176–189
Baddeley AD, Wilson BA (1986) Amnesia, autobiographical memory and confabulation. In: Rubin DC (ed) Autobiographical memory. Cambridge University Press, Cambridge MA, S 225–252
Baddeley AD (1992) Working memory. Science 255:556–559
Bender MB (1956) Single episode of confusion with amnesia. J Hillside Hosp 5:212–215
Benson DF, Djenderedjian A, Miller BL, Pachana NA, Chang L, Itti L, Mena I (1996) Neural basis of confabulation. Neurology 46:1239–1243
Benton AL (1963) The revised visual retention test. Psychological Corp., New York (deutsch: 7. Aufl. Hogrefe Testzentrale, Göttingen)
Berrol S (1990) Issues in cognitive rehabilitation. Arch Neurol 47:219–220
Blansjaar BA, Horjus MC, Nijhuis HG (1987) Prevalence of the Korsakoff syndrome in The Hague, The Netherlands. Acta Psychiatr Scand 75:604–607
Brooks DN, Baddeley AD (1976) What can amnesic patients learn? Neuropsychologia 14:111–122
Brooks N (1984) Cognitive deficits after head trauma. In: Brooks N (ed) Closed head injury. Psychological, social and family consequences. Oxford University Press, Oxford
Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349:763–765
Caplan LR (1985) Transient global amnesia. In: Vinken P, Bruyn G, Klawans H (eds) Handbook of clinical neurology, Vol 1 (45). Elsevier, Amsterdam
Castellano C, Brioni JD, McGaugh JL (1990) GABAergic Modulation of memory. In: Squire LR, Lindenlaub E (eds) The biology of memory. Schattauer, München, S 361–380
Cohen NJ, Squire LR (1980) Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that. Science 210:207–209
Copeland JR, Davidson IA, Dewey ME, Larkin BA, McWilliam C, Saunders PA, Scott LR, Sharma V, Sullivan C (1992) Alzheimer’s disease, other dementias, depression and pseudodementia: Prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 161:230–239
Cutting J (1978) The relationship between Korsakov’s syndrome and `alcoholic dementia’. Br J Psychiatry 132:240–251
Damasio AR, Eslinger JL, Damasio H, van Hoesen GW, Cornell S (1985) Multimodal amnestic syndrome following bilateral temporal and basal forebrain damage. Arch Neurol 42:252–259
Damasio AR, Graff-Radford NR, Eslinger JL, Damasio H, Kassell N (1985) Amnesia following basal forebrain lesions. Arch Neurol 42:263–271
Damasio AR, van Hoesen GW (1985) The limbic system and the localization of herpes simplex encephalitis. J Neurol, Neurosurg, Psychiatr 48:297–301
Delis DC, Lucas JA (1996) Memory. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 365–399
Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y (1997) Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45:321–328
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl., Huber, Bern
Engelborghs S, Marien P, Pickut BA, Verstraeten S, De Deyn PP (2000) Loss of psychic self-activation after paramedian bithalamic infarction. Stroke 31:17621765
Eustache F, Desgranges B, Petit-Taboue MC, de la Sayette V, Piot V, Sable C, Mar-chal G, Baron JC (1997) Transient global amnesia: implicit/explicit memory dissociation and PET assessment of brain perfusion and oxygen metabolism in the acute stage. J Neurol Neurosurg Psychiatry 63:357–367
Eustache F, Desgranges B, Laville P, Guillery B, Lalevee C, Schaeffer S, de la Sayette V, Iglesias S, Baron JC, Viader F (1999) Episodic memory in transient global amnesia: encoding, storage, or retrieval deficit? J Neurol Neurosurg Psychiatry 66:148–154
Evans J, Wilson B, Wraight EP, Hodges JR (1993) Neuropsychological and SPECT scan findings during and after transient global amnesia: evidence for the differential impairment of remote episodic memory. J Neurol, Neurosurg, Psychiatry 56:1227–1230
Ewert J, Levin HS, Watson MG, Kalisky Z (1989) Procedural memory during post-traumatic amnesia in survivors of severe closed head injury. Arch Neurol 46:911916
Feuerlein W, Küfner H, Flohrschütz T (1994) Mortality in alcoholic patients given inpatient treatment. Addiction 89:841–849
Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. TINS 14:220–223
Fink GR, Markowitsch HJ (2000) Schädel-Hirn-Traumata. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 332–353
Fisher CM (1982) Transient global amnesia. Precipitating activities and other observations. Arch Neurol 39:605–608
Fisher CM, Adams RD (1964) Transient global amnesia. Acta Neurol Scand 40 Suppl 9:7–83
Frank G (1981) Amnestische Episoden. Psychiatry Series 25. Springer, Berlin
Franklin JE, Francis RJ (1992) Alcohol-induced organic mental disorders. In: Yudofsky SC, Hales RE (eds) Textbook of neuropsychiatry. American Psychiatric Press. Washington, S 563–583
Fujii K, Sadoshima S, Ishitsuka T, Kusuda K, Kuwabara Y, Ichiya Y, Fujishima M (1989) Regional cerebral blood flow and metabolism in patients with transient global amnesia. A positron emission tomography study. J Neurol, Neurosurg, Psychiatr 52:622–630
Gass A, Gaa J, Hirsch J, Schwartz A, Hennerici MG (1999) Lack of evidence of acute ischemic tissue change in transient global amnesia on single-shot echo-planar diffusion-weighted MRI. Stroke 30:2070–2072
George AE, de Leon MJ, Stylopoulos LA, Miller J, Kluger A, Smith G, Miller DC (1990) CT diagnostic features of Alzheimer disease: importance of the choroidal/ hippocampal fissure complex. Am J Neuroradiol 11:101–107
Gibson GA, Duffy TE (1981) Impaired synthesis of acetyl-choline by mild hypoxia and nitrous oxide. J Neurochem 36:28–37
Gibson GA, Pulsinelli W, Blass JP, Duffy TE (1981) Brain dysfunction in mild to moderate hypoxia. JAMA 70:1247–1254
Gilbert PFC (1974) A theory of memory that explains the function and structure of the cerebellum. Brain Res 70:1–18
Glisky EL, Schacter DL, Tulving E (1986) Computer learning by memory-impaired patients: acquisition and retention of complex knowledge. Neuropsychologia 24:313–328
Goodwin DW, Othmer E, Halikas JA, Freemon F (1971) Loss of short-term memory as a predictor of the alcoholic `blackout’. Nature 227:201–202
Grant DA, Berg BA (1994) Wisconsin card sorting test (WCST).2ndedn. (deutsch: Hogrefe Testzentrale, Göttingen)
Guberman A, Stuss D (1983) The syndrome of bilateral paramedian thalamic infarction. Neurology 33:540–546
Guidotti M, Anzalone N, Morabito A, Landi G (1989) A case-control study of transient global amnesia. J Neurol, Neurosurg, Psychiatry 52:320–323
Hacke W, Zeumer H (1981) Computertomographie bei Herpes-simplex-Encephalitis. Fortschr Röntgenstr 135:426–431
Hambrecht M (1987) Gedächtnisstörungen bei Frontalhirnläsionen. Nervenarzt 58:131–136
Harding A, Halliday G, Caine D, Kril J (2000) Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 123:141–154
Hartje W, Sturm W (2000) Amnesie. In: Hartje W, Poeck K (Hrsg) Klinische Neuropsychologie, 4. Aufl. Thieme, Stuttgart, S 208–239
Haupt M, Kurz A, Pollmann S, Romero B (1992) Psychopathologische Störungen bei beginnender Alzheimerscher Krankheit. Fortschr Neurol Psychiatr 60:3–7
Heathfield KWG, Croft PB, Swash M (1973) The syndrome of transient global amnesia. Brain 96:729–736
Hinge HH, Jensen TS, Kjaer M, Marquardsen J, Olivarius BF (1987) The prognosis of transient global amnesia. Results of a multicenter study. Neurology 37:673–676
Hodges JR, Warlow CP (1990) Syndromes of transient amnesia: towards classification. A study of 153 cases. J Neurol, Neurosurg, Psychiatr 53:834–843
Hodges JR, Warlow CP (1990) The aetiology of transient global amnesia. Brain 113:637–657
Hodges JR, McCarthy RA (1995) Loss of remote memory: a cognitive neuropsychological perspective. Curr Opin Neurobiol 5:178–183
Horowitz AL, Kaplan R, Sarpel G (1987) Carbon monoxide toxicity: MR imaging in the brain. Radiology 162:787–788
Hunter R, McLuskie R, Wyper D, Patterson J, Christie JE, Brooks DN, McCulloch J, Fink G, Goodwin GM (1989) The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with99mTcHMPAO in patients with presenile Alzheimer’s disease and Korsakoff’s psychosis. Psychol Med 19:847–855
Inzitari D, Pantoni L, Lamassa M, Pallanti S, Pracucci G, Marini P (1997) Emotional arousal and phobia in transient global amnesia. Arch Neurol 54:866–873
Jacobson RR, Acker CF, Lishman WA (1990) Patterns of neuropsychological deficit in alcoholic Korsakoff’s syndrome. Psychol Med 20:321–334
James W (1890) Principles of psychology. Holt, Rinehart & Winston, S 648
Jensen TS, de Olivarius BF (1981) Transient global amnesia - its clinical and pathophysiological basis and prognosis. Acta Neurol Scand 63:220–230
John U, Veltrup C, Schnofl A, Wetterling T, Kanitz R-D, Dilling H (1991) Gedächtnisdefizite Alkoholabhängiger in den ersten Wochen der Abstinenz. Z Klin Psychol Psychopathol Psychother 39:348–356
Jovin TG, Vitti RA, McCluskey LF (2000) Evolution of temporal lobe hypoperfusion in transient global amnesia: a serial single photon emission computed tomography study. J Neuroimaging 10:238–241
Joyce EM, Robbins TW (1991) Frontal lobe function in Korsakoff and nonKorsakoff alcoholics: planning and spatial working memory. Neuropsychologia 29:709–723
Kapur N, Coughlan AK (1980) Confabulation and frontal lobe dysfunction. J Neu-rol, Neurosurg, Psychiatry 43:461–463
Kapur N (1993) Transient epileptic amnesia - a clinical update and a reformulation. J Neurol, Neurosurg, Psychiatry 56:1184–1190
Kessels RP, Postma A, Wester AJ, de Haan EH (2000) Memory for object locations in Korsakoff’s amnesia. Cortex 36:47–57
Khan AU (1986) Clinical disorders of memory. Plenum, New York
Kimura D (1963) Right temporal lobe damage. Arch Neurol 8:264–271
Klimesch W (1990) Gedächtnis: Klassifikation und Diagnostik. In: Baumann U, Perrez M (Hrsg) Klinische Psychologie, Band 1. Huber, Bern, S 93–100
Klimesch W (1990) Gedächtnis: Ätiologie/Bedingungsanalyse. In: Baumann U, Perrez M (Hrsg) Klinische Psychologie, Band I. Huber, Bern, S 182–191
Kono E, Kono R, Shida K (1983) Computerized tomography of 34 patients at the chronic stage of acute carbon monoxide poisoning. Arch Psychiatr Nervenkrankh 233:271–278
Kopelman MD (1986) Clinical tests of memory. Br J Psychiatry 148:517–525
Kopelman MD (1987) Amnesia: organic and psychogenic. Br J Psychiatry 150: 428–442
Kopelman MD, Wilson BA, Baddeley AD (1989) The Autobiographical Memory Interview: a new assessment of autobiographical and personal semantic memory in amnesic patients. J Clin Exp Neuropsychol 11:724–744
Kopelman MD (1991) Frontal dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-type dementia. Brain 114:117–137
Kopelman MD, Stanhope N, Kingsley D (1997) Temporal and spatial context memory in patients with focal frontal, temporal lobe, and diencephalic lesions. Neuropsychologia 35:1533–1545
Kopelman MD, Stanhope N (1998) Recall and recognition memory in patients with focal frontal, temporal lobe and diencephalic lesions. Neuropsychologia 36:785–795
Kopelman MD, Stanhope N, Kingsley D (1999) Retrograde amnesia in patients with diencephalic, temporal lobe or frontal lesions. Neuropsychologia 37:939958
Korsakoff SS (1891) Ueber besondere Erinnerungstörungen (Pseudoreminiscenzen) bei polyneuritischer Psychose. Allg Z Psychiatr 47
Koski KJ, Marttila RJ (1990) Transient global amnesia: incidence in an urban population. Acta Neurol Scand 81:358–360
Kral VA (1962) Senescent forgetfullness: benign and malignant. Can Med Ass J 86:257–260
Kratz B, Schröder J, Pantel J, Weimer D, Minnemann E, Lehr O, Sauer H (1998) Leichte kognitive Beeinträchtigung im Alter. Nervenarzt 69:975–982
Kritchevsky M, Graff-Radford, Damasio AR (1987) Normal memory after damage to medial thalamus. Arch Neurol 44:959–962
Kushner MJ, Hauser WA (1985) Transient global amnesia: a case-control study. Ann Neurol 18:684–691
Ladurner G, Skvarc A, Sager WD (1982) Computer tomography in transient global amnesia. Eur Neurol 21:34–40
Lauria G, Gentile M, Fassetta G, Casetta I, Caneve G (1997) Incidence of transient global amnesia in the Belluno province, Italy: 1985 through 1995. Results of a community-based study. Acta Neurol Scand 95:303–310
Lauria G, Gentile M, Fassetta G, Casetta I, Caneve G (1998) Transient global amnesia and transient ischemic attack: a community-based case-control study. Acta Neurol Scand 97:381–385
Lewis SL (1998) Aetiology of transient global amnesia. Lancet 352 (9125):397–399
Lezak MD (1995) Neuropsychological assessment3rdedn. Oxford University Press, Oxford
Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA (2000) The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 57:581–590
Lishman WA (1990) Alcohol and brain. Br J Psychiatry 156:635–644
Luria AR (1976) The neuropsychology of memory. Wiley, New York
MacKinnon S, Squire LR (1989) Autobiographical memory in amnesia. Psychobiology 17:247–252
Markowitsch HJ (1992) Das gestörte Altgedächtnis: Diagnoseverfahren bei Hirngeschädigten. Rehabilitation 31:11–19
Markowitsch HJ (1997) Neuropsychologie des Gedächtnisses. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 71–83
Markowitsch HJ (1999) Functional neuroimaging correlates of functional amnesia. Memory 7:561–583
Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH (1984) Central nervous system catecholamine metabolism in Korsakoff’s psychosis. Ann Neurol 15:184–187
McEntee WJ, Mair RG (1990) The Korsakoff’s syndrome: a neurochemical perspective. TINS 13:340–344
Meltzer P, Rudolph M, Voshage J, Nickel B (1991) Zum Begriff der Amnesie and zur quantitativen Beurteilung nmestischer Störungen. Fortschr Neurol Psychiatr 59:207–215
Metzler P, Voshage J, Rösler P (1992) Berliner Amnesietest. Hogrefe Testzentrale, Göttingen
Mesulam MM (1990) Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 28:597–613
Miller E (1992) Psychological approaches to the management of memory impairments. Br J Psychiatry 160:1–6
Miller GA (1956) The magical number seven: plus or minus two. Some limits on our capacity for processing information. Psychol Rev 9:81–97
Miller JW, Petersen RC, Metter EJ, Millikan CH, Yanagihara T (1987a) Transient global amnesia: clinical characteristics and prognosis. Neurology 37:733–737
Miller JW, Yanagihara T, Petersen RC, Klass DW (1987) Transient global amnesia and epilepsy. Electroencephalographic distinction. Arch Neurol 44:629–633
Moss MB, Abert MS, Butters N, Payne M (1986) Differential patterns of memory loss among patients with Alzheimer’s disease, Huntington’s disease, and alcoholic Korsakoff’s syndrome. Ann Neurol 43:239–246
Mumenthaler M, Treig T (1984) Amnestische Episoden. Analyse von 111 eigenen Beobachtungen. Schw med Wschr 114:1163–1170
Netter P (1988) Individual differences in benzodiazepine-induced changes of memory. In: Hindmarch I, Ott H (eds) Benzodiazepine, receptor ligands, memory and information processing. Springer, Berlin, S 90–113
O’Boyle CA (1988) Benzodiazepine-induced amnesia and anaesthetic practice: a review. In: Hindmarch I, Ott H (eds) Benzodiazepine, receptor ligands, memory and information processing. Springer, Berlin, S 146–165
O’Brien JT, Wolf PA, Bachman DL (1992) Do subjective memory complaints precede dementia? Int J Geriat Psychiatry 7:481–486
O’Connor DW, Politt PA, Hyde JB, Fellows JL, Miller ND, Roth M (1990) A follow-up study of dementia diagnosed in the community using the Cambridge mental disorders of the elderly examination. Acta Psychiatr Scand 81:78–82
Olesen J, Jörgensen MB (1986) Leao’s spreading depression in the hippocampus explains transient global amnesia: a hypothesis. Acta Neurol Scand 73:219–220
Pantoni L, Lamassa M, Inzitari D (2000) Transient global amnesia: a review emphasizing pathogenic aspects. Acta Neurol Scand 102:275–283
Paulsen O, Moser EI (1998) A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 21:273–278
Peters UH (1994) Wörterbuch der Psychiatrie, 3. Aufl. Urban & Schwarzenberg, München
Pillmann F, Broich K (1998) Transitorische globale Amnesie - psychogene Auslösung einer organischen Störung? Psychopathologisches Bild and pathogenetische Überlegungen. Fortschr Neurol Psychiat 66:160–163
Pillon B, Deweer B, Agid Y, Dubois B (1993) Explicit memory in Alzheimer’s, Huntington’s, and Parkinson’s diseases. Arch Neurol 50:374–379
Press GA, Amaral DG, Squire LR (1989) Hippocampal abnormalities in amnestic patients revealed by high-resolution magnetic resonance imaging. Nature 341: 54–57
Primavera A, Novello P, Stara S (1993) Transient global amnesia: a quantified electroencephalographic study. Acta Neurol Scand 87:115–117
Rak A (1998) Die Behandlung von Gedächtnisstörungen. In: Kasten E, Schmid G, Eder R (Hrsg) Effektive neuropsychologische Behandlungsmethoden. Deutscher Psychologen Verlag, Bonn, S 91–124
Reed LJ, Marsden P, Lasserson D, Sheldon N, Lewis P, Stanhope N, Guinan E, Kopelman MD (1999) FDG-PET analysis and findings in amnesia resulting from hypoxia. Memory 7:599–612
Reischies FM (1997). Normales Altern und leichte Demenz. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 366–377
Reisecker F, Deisenhammer E, Forstner K (1985) Die transiente globale Amnesie. Wien klin Wschr 97:790–795
Rey A (1964) L’examen clinique en psychologie: Presses Universitaires de France, Paris
Riedmann G, Lindner M, Barolin GS (1988) Amnestische Episoden. Wien med Wschr 23/24:622–629
Rittmann M, von Kummer R, Betz H (1984) Zerebrale Angiographie bei transitorischer globaler Amnesie. Nervenarzt 55:644–650
Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L (1998) A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 55:395–401
Russell WR, Smith A (1961) Post-traumatic amnesia in closed head injury. Arch Neurol 5:4–17
Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP, Nobler MS (2000) Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J ECT 16:110–120
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57:425–434
Sander D, Winbeck K, Etgen T, Knapp R, Klingelhöfer J, Conrad B (2000) Disturbance of venous flow patterns in patients with transient global amnesia. Lancet 356(9246):1982–1984
Santos S, Lopez del Val J, Tejero C, Iniguez C, Lalana JM, Morales F (2000) Amnesia global transitoria: revision de 58 casos. Rev Neurol 30:1113–1117
Sarter M, Sterkens DN (1988) ß-Carbolines as tools in memory research: animal data and speculation. In: Hindmarch I, Ott H (eds) Benzodiazepine, receptor ligands, memory and information processing. Springer, Berlin, S 230–245
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual. DSM-IV, 3. Aufl. Hogrefe, Göttingen
Schmidtke K, Ehmsen L (1998) Transient global amnesia and migraine. A case control study. Eur Neurol 40:9–14
Schmidtke K, Reinhardt M, Krause T (1998) Cerebral perfusion during transient global amnesia: findings with HMPAO SPECT. J Nucl Med 39:155–159
Schnider A, Ptak R, von Daniken C, Remonda L (2000) Recovery from spontaneous confabulations parallels recovery of temporal confusion in memory. Neurology 55:74–83
Schroth G, Kretschmar K, Gawehn J, Voigt K (1987) Advantage of magnetic resonance imaging in the diagnosis of cerebral infections. Neuroradiology 29:120126
Seltzer B, Benson DF (1974) The temporal pattern of retrograde amnesia in Korsakoff’s disease. Neurology 24:527–530
Shallice T, Fletcher P, Frith CD, Grasby P, Frackowiak RS, Dolan RJ (1994) Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368:633–635
Shimamura AP (1989) Disorders of memory: the cognitive science perspective. In: Boller F, Grafman J (eds) Handbook of neuropsychology. Elsevier, Amsterdam, S 35–73
Shimamura AP, Janowsky JS, Squire LR (1990) Memory for the temporal order of events in patients with frontal lobe lesions and amnesic patients. Neuropsychologia 28:803–814
Shimamura AP, Gershberg FB (1992) Neuropsychiatric aspects of memory and amnesia. In: Yudofsky SC, Hales RE (eds) Textbook of neuropsychiatry, 2“ edn. American Psychiatric Press, Washington, S 345–362
Skvarc A, Ladurner G, Lechner H (1984) Verlauf globaler transitorischer Amnesie. Nervenarzt 55:72–74
Squire LR, Slater PC (1983) ECT and complaints of memory dysfunction, a prospective three-year follow-up study. Br J Psychiatry 142:1–8
Squire LR, Alvarez P (1995) Retrograde amnesia and memory consolidation: a neurological perspective. Curr Opin Neurobiol 5:169–177
Stark CE, Squire LR (2000) fMRI activity in the medial temporal lobe during recognition memory as a function of study-test interval. Hippocampus 10:329–337
Stillhard G, Landis T, Schiess R, Regard M, Sialer G (1990) Bitemporal hypoperfusion in transient global amnesia: a 99m-Tc-HM-PAO SPECT and neuropsychological findings during and after an attack. J Neurol, Neurosurg, Psychiatry 53:339–342
Strupp M, Brüning R, Wu RH, Deimling M, Reiser M, Brandt T (1998) Diffusion-weighted MRI in transient global amnesia: elevated signal intensity in the left mesial temporal lobe in 7 of 10 patients. Ann Neurol 43:164–170
Stuss DT, Alexander MP, Lieberman A, Levine H (1978) An extraordinary form of confabulation. Neurology 28:1166–1172
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL (1987) Anticholinergic sensitivity in patients with dementia of the Alzheimer Type and age-matched controls. Arch Gen Psychiatry 44:418–426
Sweeney DF (1989) Alcohol versus mnemosyne-blackouts. J Subst Abuse Treat 6:159–162
Tanabe H, Hashikawa K, Nakagawa Y, Ikeda M, Yamamoto H, Harada K, Tsumoto T, Nishimura T, Shiraishi J, Kimura K (1991) Memory loss due to transient hypoperfusion in the medial temporal lobes including hippocampus. Acta Neu-rol Scand 84:22–27
Taylor PJ, Kopelman MD (1984) Amnesia for criminell offences. Psychol Med 14:581–588
Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP (1990) Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci 240:28–33
Tierney MC, Szalai JP, Snow WG, Fisher RH (1996) The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. Arch Neurol 53:423–427
Ungerer A, Mathis C, Melan C (1998) Are glutamate receptors specifically implicated in some forms of memory processes? Exp Brain Res 123:45–51
Vakil E, Grunhaus L, Nagar I, Ben-Chaim E, Dolberg OT, Dannon PN, Schreiber S (2000) The effect of electroconvulsive therapy (ECT) on implicit memory: skill learning and perceptual priming in patients with major depression. Neuropsychologia 38:1405–1414
Vgontzas AN, Kales A, Bixler EO (1995) Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics. Pharmacology 51:205–223
Victor M, Adams RD, Collins GH (1989) The Wernicke-Korsakoff syndrome, 2nd edn. Davis, Philadelphia
Visser PJ, Krabbendam L, Verhey FR, Hofman PA, Verhoeven WM, Tuinier S, Wester A, Den Berg YW, Goessens LF, Werf YD, Jolles J (1999) Brain correlates of memory dysfunction in alcoholic Korsakoff’s syndrome. J Neurol Neurosurg Psychiatry 67:774–778
Volpe BT, Hirst W (1983) The characterization of an amnestic syndrome following hypoxic ischemic injury. Arch Neurol 40:436–440
Volpe BT, Herscovitch P, Raichle ME (1984) PET evaluation in patients with amnesia after cardiac arrest. Stroke 15:16
Volpe BT, Holtzman JD, Hirst W (1986) Further characterization of patients with amnesia after cardiac arrest: perserved recognition memory. Neurology 36:408411
Volpe BT, McDowell FH (1990) The efficacy of cognitive rehabilitation in patients with traumatic brain injury. Arch Neurol 47:220–222
Von Cramon D, Hebel N (1989) Lern-und Gedächtnisstörungen bei fokalen zerebralen Gewebsläsionen. Fortschr Neurol Psychiatr 57:544–550
Wechsler DA (1945) A standardized memory scale for clinical use. J Psychol 19:87–95 (deutsch: Hogrefe Testzentrale, Göttingen)
Wernicke C (1891) Lehrbuch der Gehirnkrankheiten für Ärzte und Studierende. 2. Aufl. T. Fischer, Kassel, S 229–242
Wetterling T (1995) Amnestisches Syndrom - Stand der Forschung. Fortschr Neurol Psychiatr 63:402–410
Wetterling T (2000) Alkoholfolgeerkrankungen. In: Förstl H (Hrsg) Klinische Neuropsychiatrie. Thieme, Stuttgart, S 354–366
Wetterling T (2001) Gerontopsychiatrie - Ein Leitfaden für Diagnostik und Therapie. Springer, Berlin
Wetterling T, Michels R, Dilling H (1998) Elektrokrampftherapie bei therapieresistenter Altersdepression. Nervenarzt 69:617–621
Wetterling T, Junghanns K (2001) Auswertung der Basisdokumentationsdaten der Lübecker psychiatrischen Universitätsklinik 1990–1998 (MUL). Unveröffentlicht
Wolkowitz OM, Weingartner H, Thompson K, Pickar D, Paul SM, Hommer DW (1987) Diazepam-induced amnesia: a neuropharmacological model of an `organic amnestic syndrome’. Am J Psychiatry 144:25–29
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Wysowski D, Barash KD (1991) Adverse behavioral reactions attributed to trizolam in the Food and Drug Administration’s spontaneous reporting system. Arch Intern Med 151:2003–2008
Yasuno F, Nishikawa T, Nakagawa Y, Ikejiri Y, Tokunaga H, Mizuta I, Shinozaki K, Hashikawa K, Sugita Y, Nishimura T, Takeda M (2000) Functional anatomical study of psychogenic amnesia. Psychiatry Res 99:43–57
Zorzon M, Longo R, Mase G, Biasutti E, Vitrani B, Cazzato G (1998) Proton magnetic resonance spectroscopy during transient global amnesia. Effect of cognitive rehabilitation on outcomes for persons with traumatic brain injury: a systematic review. J Neurol Sci 156:78–82
Literatur
Ackenheil M, Athen D, Beckmann H (1978) Pathophysiology of delirious states. J Neural Trans, Suppl 14:167–175
Albert MS, Levkoff SE, Reilly C, Liptzin B, Pilgrim D, Cleary PD, Evans D, Rowe W (1992) The delirium symptom interview: an interview for the detection of delirium in hospitalized patients. J Geriatr Psychiatr Neurol 5:14–21
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. Third edition (DSM III). American Psychiatric Press, Washington DC, S 103–123
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. Third edition, revised (DSM III-R). American Psychiatric Press, Washington DC, S 94–137
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington DC
American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156, Suppl 1–20
Anthony JC, LeResche L, Niaz U, von Körff MR, Folstein MF (1982) Limits of the “Mini-Mental-State” as a screening test for dementia and delirium among hospital patients. Psychol Med 12:397–408
Anton RF, Becker HC (1995) Pharmacotherapy and pathophysiology of alcohol withdrawal. In: Kranzler HR (eds) The pharmacology of alcohol abuse. Springer, Berlin, S 315–368
Athen D, Beckmann H, Ackenheil M, Markianos E (1977) Biochemical investigations into the alcoholic delirium: alterations of biogenic amines. Arch Psychiat Nervenkr 224:129–140
Ballenger JC, Post RM (1978) Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 133:1–14
Banger M, Philipp M, Herth T, Hebenstreit M, Aldenhoff J (1992) Development of a rating scale for quantitative measurement of the alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci 241:241–246
Basavaraju N, Phillips SL (1989) Cortisol deficient state. A cause of reversible cognitive impairment and delirium in the elderly. J Am Geriatr Soc 37:49–51
Beaver KM, Gavin TJ (1998) Treatment of acute anticholinergic poisoning with physostigmine. Am J Emerg Med 16:505–507
Berlit P (1986) Die zentrale pontine Myelinolyse. Nervenarzt 57:624–633
Birkmayer W (1978) Toxic delirium after L-Dopa medication. J Neural Transm, Suppl 14:163–166
Bohner H, Schneider F, Stierstorfer A, Weiss U, Gabriel A, Friedrichs R, Miller C, Grabitz K, Müller EE, Sandmann W (2000) Durchgangssyndrome nach gefässchirurgischen Operationen. Zwischenergebnisse einer prospektiven Untersuchung. Chirurg 71:215–221
Bonhoeffer K (1908) Zur Frage der Klassifikation der symptomatischen Psychosen. Berl Klein Wochenschr 45:2257–2260
Bonhoeffer K (1910) Die symptomatischen Psychosen im Gefolge von akuten Infektionen und inneren Erkrankungen. In: Aschaffenburg G (eds) Handbuch der Psychiatrie, Band III. Deuticke, Leipzig
Bonhoeffer K (1917) Die exogenen Reaktionstypen. Arch Psychiatr Nervenkr 58:58–70
Brauer C, Morrison RS, Silberzweig SB, Siu AL (2000) The cause of delirium in patients with hip fracture. Arch Intern Med 160:1856–1860
Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE (2000) A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 35:374–381
Camus V, Burtin B, Simeone I, Schwed P, Gonthier R, Dubos G (2000) Factor analysis supports the evidence of existing hyperactive and hypoactive subtypes of delirium. Int J Geriatr Psychiatry 15:313–316
Camus V, Gonthier R, Dubos G, Schwed P, Simeone I (2000) Etiologic and outcome profiles in hypoactive and hyperactive subtypes of delirium. J Geriatr Psychiatry Neurol 13:38–42
Christensen DB, Benfield WR (1998) Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. J Am Geriat Soc 46:620–625
Conrad K (1960) Die symptomatischen Psychosen. In: Gruhle H, Jung WR, Mayer-Gross W, Müller M (Hrsg) Psychiatrie der Gegenwart, Band II. Springer, Berlin, S 369–436
Dai YT, Lou MF, Yip PK, Huang GS (2000) Risk factors and incidence of postoperative delirium in elderly chinese patients. Gerontology 46:28–35
Dieterle L, Büchler G, Pfitzer F (1992) Zentrale pontine Myelinose. Dtsch med Wschr 117:332–336
Dilling H, Mombour W, Schmidt MH (1994) Klassifikation psychischer Krankheiten. Forschungskriterien Kapitel V (F) der ICD-10. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Klassifikation psychischer Krankheiten. Klinisch-diagnostische Leitlinien nach Kapitel V (F) der ICD-10, 3. Aufl. Huber, Bern
Djernes JK, Gutmann NC, Abelskov KE, Juul-Nielsen S, Sorensen L (1998) Psychopathologic and functional outcome in the treatment of elderly inpatients with depressive disorders, dementia, delirium and psychoses. Int Psychogeriatrics 10:7183
Doig A, Sembhi S, Livingston G (2000) Acute confusional states during treatment with risperidone. Int J Geriatr Psychiatry 15:524–525
Dolan MM, Hawkes WG, Zimmerman SI, Morrison RS, Gruber-Baldini AL, Hebel JR, Magaziner J (2000) Delirium on hospital admission in aged hip fracture patients: prediction of mortality and 2-year functional outcomes. J Gerontol A Biol Sci Med Sci 55:M527–534
Dunlap HF, Moersch FP (1934) Psychic manifestations associated with hyperthyroidism. Am J Psychiatry 91:1215–1238
Duppils GS, Wikblad K (2000) Acute confusional states in patients undergoing hip surgery. A prospective observation study. Gerontology 46:36–43
Duvoisin RC, Katz R (1968) Reversal of central anticholinergic syndrome in man by physiostigmine. JAMA 206:1965–1968
Elie M, Cole MG, Primeau FJ, Bellavance F (1998) Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 13:204–212
Engel GL, Romano J (1959) Delirium, a syndrome of cerebral insufficiency. J Chron Dis 4:260–277
Erkinjuntti T, Wikström J, Palo J, Autio L (1986) Dementia among medical inpatients. Evaluation of 2000 consecutive cases. Arch Int Med 146:1923–1926
Farrell KR, Ganzini L (1995) Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 155:2459–2464
Feuerlein W (1967) Klinisch-statistische Untersuchungen über die Entstehungsbedingungen and die Prognose des Alkoholdelirs. Nervenarzt 38:492–500
Flacker JM, Lipshitz LA (1999) Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A 54:M12–16
Flacker JM, Lipshitz LA (1999) Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 54:B239–246
Flacker JM, Lipshitz LA (2000) Large neutral amino acid changes and delirium in febrile elderly medical patients. Gerontol A Biol Sci Med Sci 55:B249–252
Folstein M, Folstein S, McHugh PR (1975) Mini-mental state: a practical guide for grading the cognitive state of patients for a clinician. J Psychiatric Res 12:189–192
Francis J, Martin D, Kapoor WN (1990) A prospective study of delirium in hospitalized elderly. JAMA 263:1097–1101
Gaertner HJ, Fischer E, Hoss J (1989) Side-effects of clozapine. Psychopharmacology 99 (Suppl):S97–100
George J, Bleasdale S, Singleton SJ (1997) Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing 26:423–427
Gibson GA, Duffy TE (1981) Impaired synthesis of acetylcholine by mild hypoxia and nitrous oxide. J Neurochem 36:28–37
Gillin JC, Sitaram N (1984) Rapid eye movement (REM) sleep: cholinergic mechanisms. Psychol Med 14:501–506
Glue P, Nutt D (1990) Overexcitement and dishibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry 157:491–499
Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6:262–270
Golinger RC, Peet T, Tune LE (1987) Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry 144:1218–1220
Greenberg R, Pearlman C (1967) Delirium tremens and dreaming. Am J Psychiatry 124:133–142
Grohmann R, Rüther E, Schmidt LG (1989) Unerwünschte Wirkungen von Psychopharmaka - Ergebnisse aus dem multizentrischen Zehnjahresprojekt AMÜP. Springer, Berlin
Gross MM, Lewis E, Naggarajan M (1973) An improved quantitative system for assessing the acute alcoholic psychoses and related states (TSA and SSA). Adv Exp Med Biol 35:365–375
Gross MM, Hastey JM (1976) Sleep disturbances in alcoholism. In: Tarter RE, Sugerman AA (eds) Alcoholism. Addison-Wesley, London
Haan J, Deppe A (1986) Zentrale pontine Myelinolyse bei Alkoholismus. Nervenarzt 57:609–612
Haensch CA, Jörg J, Baltzer F (2000) Diagnostischer and prognostischer Wert neurologischer Zusatzdiagnostik beim Alkoholdelir. Nervenarzt 71:822–828
Hawley RJ, Nemeroff CB, Bissette G, Guidotti A, Rawlings R, Linnoila M (1994) Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res 18:1312–1316
Heiser JF, Gillin JC (1971) The reversal of anticholinergic drug-induced delirium and coma with physiostigmine. Am J Psychiatry 127:1050–1054
Hewer W, Förstl H (1994) Verwirrtheitszustände im höheren Lebensalter - eine aktuelle Literaturübersicht. Psychiat Prax 21:131–138
Holzbach E, Haubritz I (1981) Faktorenanalytische Untersuchung der Symptomatologie des Delirium tremens. Suchtgefahren 27:33–40
Horenstein S, Chamberlain W, Conomy J (1967) Infarctions of the fusiform and calcarine regions with agitated delirium and hemianopia. Trans Am Neurol Assoc 92:85–89
Inouye SK (1996) Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 275:852–857
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Segal AP, Horwitz RI (1990) Clarifying confusion: the confusion assessment method. Ann Intern Med 113:941–948
Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME (1993) A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 119:474–481
Itil T, Fink T (1966) Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations. J Nery Ment Dis 143:492507
Jackson SW (1969) Galen - on mental disorders. J Hist Behav Sci 5:365–384
Jacobson SA, Leuchtner AF, Walter DO (1993) Conventional and quantitative EEG in the diagnosis of delirium among the elderly. J Neurol, Neurosurg, Psychiatry 56:153–158
Jakob H, Spalke G (1971) Klinik und Neuropathologie zentralnervöser Komplikationen nach akuten Elektrolyt-und Wasserhaushaltsstörungen unter besonderer Berücksichtigung der zentralen pontinen Myelinolyse. Fortschr Neurol Psychiat 19:169–191
John U, Veltrup C, Schnofl A, Wetterling T, Kanitz R-D, Dilling H (1991) Gedächtnisdefizite Alkoholabhängiger in den ersten Wochen der Abstinenz. Z Klin Psychol Psychopathol Psychother 39:348–356
Johnson JC, Gottlieb GL, Sullivan E, Wanich C, Kinosian B, Forciea MA, Sims R, Hogue C (1990) Using DSM III-R criteria to diagnose delirium in elderly general medical patients. J Gerontol 45:M113–M119
Jost A, Hermle L, Spitzer M, Oepen G (1992) Zur klinischen und laborchemischen Differenzierung des Alkoholentzugssyndroms („Prädelir“) und des Alkoholdelirs. Psychiat Prax 19:16–22
Kaumeier S (1984) Anticholinerge Krise. Munch med Wschr 126:77–78
Kotorii T, Nakazawa Y, Yokoyama T, Kurauchi H, Sakurada H, Ohkawa T, Nonaka K, Hasuzawa H, Dainoson K, Inanaga K (1980) The sleep pattern of chronic alcoholics during the alcohol withdrawal period. Folia Psychiatr Neurol Jpn 34:89–95
Koizumi J, Shirashi H, Ofuku K, Suzuki T (1988) Duration of delirium shortened by correction of electrolyte imbalance. Jpn J Psychiatr Neurol 42:81–88
Koponen HJ (1999) Neurochemistry and delirium. Dement Geriatr Cogn 10:339341
Koponen HJ, Partanen J, Paakonen A, Mattila E, Riekkinen PF (1989) EEG spectral analysis in delirium. J Neurol Neurosurg Psychiatry 52:980–985
Koponen HJ, Stenbäck U, Mattila E, Reinikainen K, Soininen H, Riekkinen PJ (1989) CSF beta-endorphin-like immunoreactivity in delirium. Biol Psychiat 25:938–944
Koponen HJ, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ (1989) Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 79: 579–585
Koponen HJ, Riekkinen PJ (1993) A prospective study of delirium in elderly patients admitted to a psychiatric hospital. Psychol Med 23:103–109
Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, Bruera ED (2000) Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160:786–794
Lester BK, Rundell OH, Cowden LC, Williams HL (1973) Chronic alcoholism, alcohol and sleep. Adv Exp Med Biol 35:261–279
Levkoff SE, Safran C, Cleary PD, Gallop J, Phillips RS (1988) Identification of factors associated with the diagnosis of delirium in elderly hospitalized patients. J Am Geriatr Soc 36:1099–1104
Levkoff SE, Cleary P, Liptzin B, Evans D (1991) Epidemiology of delirium: an overview of research issues and findings. Int Psychogeriat 3:149–167
Levkoff SE, Liptzin B, Cleary P, Reilly CH, Evans D (1991) Review of research instruments and techniques used to detect delirium. Int Psychogeriat 3:253–271
Linnoila M, Mefford I, Nutt D, Adinoff B (1987) Alcohol withdrawal and noradrenergic function. Ann Int Med. 107:875–889
Lipowski ZJ (1989) Delirium in the elderly patient. N Engl J Med 320:578–582
Lipowski ZJ (1990) Delirium: acute confusional states. Oxford University Press, Oxford
Liptzin B, Levkoff SE, Cleary PD, Pilgrim DM, Reilly CH, Albert M, Wetle TT (1991) An empirical study of diagnostic criteria for delirium. Am J Psychiatry 148:454–457
Liptzin B, Levkoff SE (1992) An empirical study of delirium subtypes. Br J Psychiatry 161:843–845
Löhrer F, Kaiser R (1999) Biogene Suchtmittel. Neue Konsumgewohnheiten bei jungen Abhängigen? Nervenarzt 70:1029–1033
Mach JR Jr, Dyksen MW, Kuskowski M, Richelson E, Holden L, Jilk KM (1995) Serum anticholinergic activity in hospitalized older persons with delirium: preliminary study. J Am Geriatr Soc 43:491–495
Manos PJ, Wu R (1997) The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry 9:219–226
Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, Katz N, Cook EF, Orav EJ, Lee TH (1994) The relationship of postoperative delirium with psychoactive medications. JAMA 272:1518–1522
Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, Donaldson MC, Whitemore AD, Sugarbaker DJ, Poss R, Haas S, Cook EF, Orav J, Lee TH (1994) A clinical prediction rule for delirium after elective non-cardiac surgery. JAMA 271:134–139
Marcantonio ER, Flacker JM, Michaels M, Resnick NM (2000) Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 48:618–624
Martin NJ, Stones MJ, Young JE, Bedard M (2000) Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr 12:117–127
Maxion H, Schneider E (1971) Alkoholdelir and Traumschlaf. Ergebnisse einer polysomnographischen Nachtschlaf-EEG-Untersuchung bei Patienten nach Alkoholdelir. Arch Psychiatr Nervenkr 214:116–126
Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144–151
McIntosh TK, Bush HL, Yeston NS, Grasberger R, Palter M, Aun F, Egdahl RH (1985) Beta-Endorphin, cortisol and postoperative delirium: a preliminary report. Psychoendocrinol 10:303–313
Meagher DJ, O’Hanlon D, O’Mahony E, Casey PR, Trzepacz PT (2000) Relationship between symptoms and motoric subtype of delirium. J Neuropsychiatry Clin Neurosci 12:51–56
Medina JL, Rubino FA, Ross E (1974) Agitated delirium caused by infarctions of the hippocampal formation and fusiform and lingual gyri. Neurology 24:1181–1183
Menger H, Machowski J, Jörg J, Cramer BM (1998) Pontine and extrapontine Myelinolysen. Frühdiagnostischer and prognostischer Wert von cerebralem CT and MRT. Nervenarzt 69:1083–1090
Meyer JG (1974) Säure-Basen-Veränderungen im Liquor cerebrospinalis während des alkoholischen Prädelirs. Nervenarzt 47:623–627
Mussi C, Ferrari R, Ascari S, Salvioldi G (1999) Importance of serum anticholinergic activity in the assessment of elderly patients with delirium. J Geriatr Psychiatry Neurol 12:82–86
Murray AM, Levkoff SE, Wetle TT, Beckett L, Cleary PD, Schor JD, Lipshitz LA, Rowe JW, Evans DA (1993) Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 48:M181–M186
Naughton BJ, Moran M, Ghaly Y, Michalakes C (1997) Computed tomography scanning and delirium in elder patients. Acad Emerg Med 4:1107–1110
Neumärker K-J (1989) Karl Bonhoeffer und die Stellung der symptomatischen Psychosen - Organischen Psychosen - in Klinik und Forschung. Nervenarzt 60: 593–602
Neundörfer B (1990) Das EEG bei Medikamenteneinnahme und Intoxikation. In: Neundörfer B: EEG-Fibel. Fischer, Stuttgart, S 194–207
Österreich K (1989) Verwirrtheitszustände. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart 6, 3. Aufl. Organische Psychosen. Springer, Heidelberg, S 201–225
O’Keeffe ST, Lavan JN (1999) Clinical significance of delirium subtypes in older people. Age Ageing 28:115–119
Okita Y, Takamoto S, Ando M, Morota T, Matsukawa R, Kawashima Y (1998) Mortality and cerebral outcome in patients who underwent aortic arch operations using deep hypothermic circulatory arrest with retrograde cerebral perfusion: no relation of early death, stroke, and delirium to the duration of circulatory arrest. J Thor Cardiovas Surg 115:129–138
Olsson T (1999) Activity in the hypothalamic-pituitary-adrenal axis and delirium. Dement Geriatr Cogn Disord 10:345–349
Palsson A (1986) The efficacy of early chlormethiazole medication in the prevention of delirium tremens. A retrospective study of the outcome of different drug treatment strategies at the Halsingborg psychiatric clinics. Acta Psychiat Scand 73, Suppl 329:140–145
Peters UH (1994) Wörterbuch der Psychiatrie, 3. Aufl. Urban & Schwarzenberg, München
Pro JD, Wells CE (1977) The use of the electroencephalogram in the diagnosis of delirium. Dis Nerv Syst 38:804–808
Puchstein C, van Aken H, Schneider U (1982) Intoxikationen durch anticholinerg wirkende Arzneimittel mit Physostigmin behandeln. Klinikarzt 11:1022–1026
Rabins PV, Folstein MF (1982) Delirium and dementia: diagnostic criteria and fatality rates. Br J Psychiatry 140:149–153
Rahkonen T, Luukkainen-Markkula R, Paanila S, Sivenius J, Sulkava R (2000) Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: a 2 year follow up study. J Neurol Neurosurg Psychiatry 69:519521
Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L (1998) Delirium in elderly patients treated with risperidone: a report of three cases. J Clin Psychopharmacol 18:171–172
Robertsson B, Blennow K, Gottfries CG, Wallin A (1998) Delirium in dementia. Int J Geriatric Psychiatry 13:49–56
Rockwood K, Cosway S, Carver D, Jarrett P, Stadnyk K, Fisk J (1999) The risk of dementia and death after delirium. Age Ageing 28:551–556
Rogers MP (1985) Rheumatoid arthritis: psychiatric aspects and use of psycho-tropics. Psychosomatics 26:769–778
Rolfson DB, McElhaney JE, Jhangri GS, Rockwood K (1999) Validity of the confusion assessment method in detecting postoperative delirium in the elderly. Int Psychogeriatr 11:431–438
Romano J, Engel GL (1944) Delirium, I: Electroencephalographic data. Arch Neurol Psychiatry 51:356–377
Rommelspacher H, Schmidt LG, Helmchen H (1991) Pathobiochemie und Pharmakotherapie des Alkoholentzugssyndroms. Nervenarzt 62:649–657
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und Statistisches Manual Psychischer Störung DSM-IV, 3. Aufl. Hogrefe, Göttingen
Scharfetter C (1996) Bewußtsein. In: Scharfetter, C.: Allgemeine Psychopathologie, 4. Aufl. Thieme, Stuttgart, S 47–71
Schejbal P (1987) Zentrale pontine Myelinolyse: Klinische Verlaufsbeobachtungen, computer-und kernspintomographische Befunde. Akt Neurol 14:149–152
Schmidt LG (1986) Das anticholinerge Delir und abortive Vorformen. Munch med Wschr 128:522–523
Schmidt PK, Irsigler K, Mildschuh W, Pointer H, Kryspin-Exner K (1971) Störungen des extra-und intrazellulären Wasser-und Elektrolythaushaltes im Delirium tremens. Dtsch med Wschr 96:332–336
Schnaberth G, Gell G, Jaklitsch H (1972) Entgleisung des Säure-Basen-Gleichgewichts im Liquor cerebrospinalis beim Delirium tremens. Arch Psychiatr Nervenkr 215:417–428
Schor JD, Levkoff SE, Lipshitz LA, Reilly CH, Cleary PD, Rowe JW, Evans DA (1992) Risk factors for delirium in hospitalized elderly. JAMA 267:827–831
Selbach H (1978) Das Kippschwingungsprinzip. In: Sturm A, Birkmayer W (Hrsg) Klinische Pathologie des Vegetativen Nervensystems. Fischer, Stuttgart, S 299
Sellers EM, Sullivan JT, Somer G, Sykora K (1991) Characterization of DSM III-R criteria for complicated alcohol withdrawal provides an empirical basis for DSM IV. Arch Gen Psychiatry 48:442–447
Seymour DG, Henschke PJ, Cape RDT (1980) Acute confusional states and dementia in the elderly: the role of dehydration/ volume depletion, physical illness and age. Age Aging 9:137–146
Shaw JM, Kolesar GS, Sellers EM, Kaplan HL, Sandor P (1981) Development of optimal treatment tactics for alcohol withdrawal. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1:382–388
Sipahimalani A, Masand PS (1997) Use of risperidone in delirium: case reports. Ann Clin Psychiatry 9:105–107
Sipahimalani A, Masand PS (1998) Olanzapine in the treatment of delirium. Psychosomatics 39:422–430
Sirois F (1988) Delirium: 100 cases. Can J Psychiatry 33:375–378
Smith LW, Dimsdale JE (1989) Postcardiotomy delirium: conclusions after 25 years? Am J Psychiatry 146:452–458
Sokoloff L (1981) Circulation and energy metabolism of the brain. In: Siegel GJ, Albers RW, Agranoff BW, Katzman R (eds) Basic Neurochemistry3rdedn. Little Brown Comp, Boston, S 471–495
Spittler JF (1992) Der Bewußtseinsbegriff aus neuropsychiatrischer und in interdisziplinärer Sicht. Fortschr Neurol Psychiat 60:54–65
Sullivan JT, Sykora K, Schneidermann J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for alcohol scale (CIWA-Ar). Br J Addiction 84:1353–1357
Sutton T (1813) Tracts on delirium tremens, on peritonitis and on the gout. Thomas Underwood, London, S 1–77
Tavcar R, Dernovsek MZ (1998) Risperidone-induced delirium. Can J Psychiatry 43:194
Taylor D, Lewis S (1993) Delirium. J Neurol, Neurosurg, Psychiatry 56:742–751
Thomas RI, Cameron DJ, Fahs MC (1988) A prospective study of delirium and prolonged hospital stay. Arch Gen Psychiatry 45:937–940
Tönnesen E (1982) Delirium tremens and hypokaliaemia. Lancet ii:97
Trzepacz PT, Teague GB, Lipowski ZJ (1985) Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiat 7:101–107
Trzepacz PT, Baker RW, Greenhouse J (1988) A symptom rating scale for delirium. Psychiat Res 23:89–97
Trzepacz PT, Mulsant BH, Amanda Dew M, Pasternak R, Sweet RA, Zubenko GS (1998) Is delirium different when it occurs in dementia? A study using the delirium rating scale. J Neuropsychiatry Clin Neurosci 10:199–204
Tuma R, DeAngelis LM (2000) Altered mental status in patients with cancer. Arch Neurol 57:1727–1731
Uldall KK, Harris VL, Lalonde B (2000) Outcomes associated with delirium in acutely hospitalized acquired immune deficiency syndrome patients. Compr Psychiatry 41:88–91
Van Sweden B, Mellerio F (1989) Toxic ictal delirium. Biol Psychiatry 25:449–458
Van der Mast RC, Fekkes D (2000) Serotonin and amino acids: partners in delirium pathophysiology? Semin Clin Neuropsychiatry 5:125–131
Van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Habbema JD (2000) Is delirium after cardiac surgery related to plasma amino acids and physical condition? J Neuropsychiatry Clin Neurosci 12:57–63
Vermetten E, Rutten SJ, Boon PJ, Hofman PA, Leentjens AF (1999) Neuropsychiatric and neuropsychologic manifestations of central pontine myelinolysis. Gen Hosp Psychiatry 21:296–302
Victor M, Adams RD, Collins GH (1989) The Wernicke-Korsakoff-Syndrome, 2“dedn. Davis, Philadelphia
Von Keyserlingk H (1978) Zur Epidemiologie des Delirium tremens im Bezirk Schwerin. Psychiat Neurol Med Psychol 30:483–490
Wadstein J, Skude G (1978) Does hypokaliaemia precede delirium tremens? Lancet ií:549
Webster R, Holroyd S (2000) Prevalence of psychotic symptoms in delirium. Psychosomatics 41:519–522
Wernicke C (1891) Lehrbuch der Gehirnkrankheiten für Ärzte und Studierende, 2. Aufl. T. Fischer, Kassel, S 229–242
Wetterling T (1987) Hyponatriämie - unterschätzte Komplikation bei psychiatrischen Patienten. Nervenarzt 58:625–631
Wetterling T (1994) Delir - Stand der Forschung. Fortschr Neurol Psychiat 62: 280–289
Wetterling T (1997) Delir bei älteren Patienten. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 356–365
Wetterling T (1998) Differentialdiagnose von Amnesie, Delir und Demenz. In: Schütz RM (Hrsg) Praktische Geriatrie 18. Graphische Werkstätten, Lübeck, S 56–64
Wetterling T (2000) Alkoholfolgeerkrankungen. In: Förstl H (Hrsg) Klinische Neuropsychiatrie. Thieme, Stuttgart, S 354–366
Wetterling T (2001) Psychiatrische Notfälle. In: Braun J, Preuß R (Hrsg) Klinikleitfaden Intensivmedizin, 5. Aufl. Urban und Fischer, Stuttgart
Wetterling T, Kanitz R-D, Veltrup C, Driessen M (1994) Clinical predictors of alcohol withdrawal delirium. Alcohol Clin Exp Res 18:1100–1102
Wetterling T, Kanitz R-D, Besters B, Fischer D, Zerfass B, John U, Spranger H, Driessen M (1997) A new rating scale for the assessment of the alcohol withdrawal syndrome (AWS-Scale) - as a basis for a score-controlled inpatient treatment. Alcohol Alcohol 32:753–760
Wetterling T, Kanitz R-D, Driessen M, Junghanns K (2001) Severity of alcohol withdrawal syndrome - age-dependent? Alcohol Alcohol 36:75–78
Wieck HH (1971) Neuropsychiatrie der Komazustände. Fortschr Med 89:945–948
Wise MG, Brandt GT (1992) Delirium. In: Hales RE, Yudofsky SC (eds) Textbook of Neuropsychiatry, 2“aedn. American Psychiatric Press, Washington, S 291–310
Wojnar M, Bizon Z, Wasilewski D (1999) Assessment of the role of kindling in the pathogenesis of alcohol withdrawal seizures and delirium tremens. Alcohol Clin Exp Res 23:204–208
Wojnar M, Bizon Z, Wasilewski D (1999) The role of somatic disorders and physical injury in the development and course of alcohol withdrawal delirium. Alcohol Clin Exp Res 23:209–213
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Zarcone U (1979) Alcoholism and sleep. In: Passonant P, Oswald I (eds) Pharmacology of the states of alertness. Oxford Pergamon Press, Oxford, S 9–38
Literatur
Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol 74:209–225
Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiat 37:121–130
Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T (1993) The course of geriatric depression with “reversible dementia”: a controlled study. Am J Psychiatry 150:1693–1699
Almkvist O (1994) Neuropsychological deficits in vascular dementia in relation to Alzheimer’s disease: reviewing evidence for functional similarity or divergence. Dementia 5:203–209
Amaducci L, Angst J, Bech P, Benkert O, Bruinvels J, Engel RR, Gottfries CG, Hippius H, Levy R, Lingjaerde O, Lopez-Ibor JJ, Orgogozo JM, Pull C, Saletu B, Stoll KD, Woggon B (1990) Consensus Conference on the Methodology of Clinical Trials of “Nootropics”, Munich, June 1989. Pharmacopsychiatry 23:171–175
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. Third edition (DSM III). American Psychiatric Press, Washington DC, S 103–123
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. Third edition, revised (DSM III-R). American Psychiatric Press, Washington DC, S 94–137
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington DC
Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53:1992–1997
Anthony JC, LeResche L, Niaz U, von Körff MR, Folstein MF (1982) Limits of the “Mini-Mental-State” as a screening test for dementia and delirium among hospital patients. Psychol Med 12:397–408
Arolt V, Driessen M, Bangert-Verleger A, Neubauer H, Schürmann A, Seibert W (1995) Psychische Störungen bei internistischen and chirurgischen Krankenhauspatienten. Prävalenz and Behandlungsbedarf. Nervenarzt 66:670–677
Ashe J, Rosen SA, McArthur JC, Davis LE (1993) Bacterial, fungal, and parasitic causes of dementia. In: Whitehouse PJ (ed) Dementia. Davis, Philadelphia, S 276–306
Ballard C, McKeith I, O’Brien J, Kalaria R, Jaros E, Ince P, Perry R (2000) Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 11:59–65
Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R (2000) Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59:97–106
Barclay LL, Zemcov A, Blass JP, Sansone J (1985) Survival in Alzheimer’s disease and vascular dementias. Neurology 35:834–840
Berrios G (2000) Dementia: historical overview. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2“dedn. Arnold, London, S 3–13
Bickel H (1999) Epidemiologie der Demenzen. In: Förstl H, Bickel H, Kurz A (Hrsg) Alzheimer Demenz. Grundlagen, Klinik and Therapie. Springer, Berlin, S 9–32
Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797–811
Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349:763–765
Bracco L, Gallato R, Grigoletto F, Lippi A, Amaducci L, SMID group (1989) Survival in presenile and senile Alzheimer’s disease. J Neural Transm (P-D Sect) 1:39
Bracco L, Campani D, Baratti E, Lippi A, Inzitari D, Pracucci G, Amaducci L (1993) Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci 120:131–136
Breteler MMB, Bots ML, Ott A, Hofman A (1998) Risk factors for vascular disease and dementia. Haemostasis 28:167–173
Brodaty H, Moore CM (1997) The clock drawing test for dementia of the Alzheimer’s type: a comparison of three scoring methods in a memory disorders clinic. Int J Geriatr Psychiatry 12:619–629
Brodaty H, Green A (2000) Family carers for people with dementia. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2ndedn. Arnold, London, S 193–205
Brun A (1994) Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 5:145–147
Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19:253–262
Brun A, Gustafson L (1988) Zerebrovaskuläre Erkrankungen. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart 6, 3. Aufl. Springer, Heidelberg, S 253–295
Capizzano AA, Schuff N, Amend DL, Tanabe JL, Norman D, Maudsley AA, Jagust W, Chui HC, Fein G, Segal MR, Weiner MW (2000) Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy. Am J Neuroradiol 21:621–630
Chandra V, Bharucha NE, Schoenberg BS (1986) Conditions associated with Alzheimer’s disease at death: case-control study. Neurology 36:209–211
Chui HC (1989) Dementia. A review emphasizing clinicopathologic correlation and brain-behavior relationships. Arch Neurol 46:806–814
Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A (1999) Variability in annual Mini-Mental-State Examination score in patients with probable Alzheimer’s disease: a clinical perspective of the data from the Consortium to Establish a Registry for Alzheimer’s Disease. Arch Neurol 56: 857–862
Clarke R, Joachim C, Esiri M, Morris J, Bungay H, Molyneux A, Budge M, Frost C, King E, Barnetson L, Smith AD (2000) Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia. Ann N Y Acad Sci 903:497–500
Cooper B, Mahnkopf B, Bickel H (1984) Psychische Erkrankungen and soziale Isolation bei älteren Heimbewohnern: eine Vergleichsstudie. Z Gerontol 17:117125
Cooper B, Bickel H, Schäufele M (1992) Demenzerkrankungen and leichtere kognitive Beeinträchtigungen bei älteren Patienten in der ärztlichen Allgemeinpraxis. Nervenarzt 63:551–560
Copeland JRM, Dewey ME (1985) Differential diagnosis: depression versus dementia. In: Traber J, Gispen WH (eds) Senile dementia of the Alzheimer type. Springer, Berlin, S 72–83
Copeland JRM, Dewey ME, Griffiths-Jones HM (1986) A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 16:89–99
Copeland JRM, Davidson IA, Dewey ME, Larkin BA, McWilliam C, Saunders PA, Scott LR, Sharma V, Sullivan C (1992) Alzheimer’s disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 161:230–239
Cummings JL (1986) Subcortical dementia. Neuropsychology, neuropsychiatry, and pathopsychology. Br J Psychiatry 149:682–689
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454
Cummings JL, Miller B, Hill MA, Neshkes R (1987) Delusions, depression, and hallucinations were assessed in 30 patients with dementia of the Alzheimer type (DAT) and 15 with multi-infarct dementia. Arch Neurol 44:389–393
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58:376–388
DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27:457–464
DeLeeuw F-E, de Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, Hof-man A, Jolles J, van Gijn J, Breteler MMB (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9–14
Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y (1997) Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45:321–328
Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y (1997) The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 54:257–263
Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R (1998) A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer’s disease. Am J Psychiatry 155:1512–1520
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien. 3. Aufl. Huber, Bern
Dunn B, Owen A, Sahakian B (2000) Neuropsycholoical assessment of dementia. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2.ndedn. Arnold, London, S 4959
Englund E, Brun A, Alling A (1988) White matter changes in dementia of Alzheimer’s type. Brain 111:1425–1439
Erkinjuntti T, Wikström J, Palo J, Autio L (1986) Dementia among medical inpatients. Evaluation of 2000 consecutive cases. Arch Int Med 146:1923–1926
Erkinjuntti T, Laaksoonen R, Sulkava R, Syrjölinen R, Palo J (1986) Neuropsychological differentiation between normal aging, Alzheimer’s disease and vascular dementia. Acta Neurol Scand 74:393–403
Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau R (1988) Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol, Neurosurg, Psychiat 51:1037–1044
Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V (1997) The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337:1667–1674
Erkinjuntti T, Bowler JV, DeCarli CS, Fazekas F, Inzitari D, O’Brien JT, Pantoni L, Rockwood K, Scheltens P, Wahlund LO, Desmond DW (1999) Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord 13 Suppl 3:81–90
Erzigkeit H (1989) Der SKT-Ein Kurztest zur Erfassung von Gedächtnis-und Aufmerksamkeitsstörungen. Beltz, Weinheim
Erzigkeit H, Lehfeld H, Branik M (1991) Überlegungen zur Anwendung von psychometrischen Testverfahren bei der Diagnostik und Therapiekontrolle dementieller Erkrankungen. In: Möller H-J (Hrsg) Hirnleistungsstörungen im Alter. Springer, Berlin, S 11–27
Ettlin TM, Staehelin HB, Kischka U, Ulrich J, Scollo-Lavizzari G, Wiggli U, Seiler WO (1989) Computed tomography, electroencephalography, and clinical features in the differential diagnosis of senile dementia. A prospective clinicopathologic study. Arch Neurol 46:1217–1220
Feldmann E, Plum F (1993) Metabolic dementia. In: Whitehouse PJ (ed) Dementia. Davis, Philadelphia, S 307–336
Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14:220–223
Foli S, Shah A (2000) Measurement of behavioural disturbance, non-cognitive symptoms and quality of life. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2°dedn. Arnold, London, S 87–100
Folstein M, Folstein S, McHugh PR (1975) Mini-mental state: a practical for grading the cognitive state of patients for the clinician. J Psychiatric Res 12:89–192
Forsell Y, Jorm AF, Fratiglioni L, Grut M, Winblad B (1993) Application of DSMIII-R criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatry 150:1199–1202
Förstl H, Burns A, Luthert P, Cairns A (1991) Demenz und internistische Erkrankungen. Z Gerontol 24:91–93
Frisoni GB, Bianchetti A, Trabucchi M, Pizzolato G (1992) SPECT and dementia. Neurology 42:1850–1851
Frölich L, Maurer K (1997) Klinische Untersuchung und Psychometrie. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 84–94
Garde E, Mortensen EL, Krabbe K, Rostrup E, Larsson HBW (2000) Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 356:628–634
George AE, de Leon MJ, Gentes CI, Miller J, London E, Budzilovich GN, Ferris S, Chase N (1986) Leucoencephalopathy in normal and pathologic ageing: 1. CT of brain lucencies. Am J Neuroradiol 7:561–566
George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N (1986) Leucoencephalopathy in normal and pathologic ageing: 2. MRI of brain lucencies. Am J Neuroradiol 7:567–570
George AE, de Leon MJ, Stylopoulos LA, Miller J, Kluger A, Smith G, Miller DC (1990) CT diagnostic features of Alzheimer disease: importance of the choroidal/ hippocampal fissure complex. Am J Neuroradiol 11:101–107
Gertz HJ (1997) Nootropika. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 163–171
Gorelick PB (1997) Status of risk factors for dementia associated with stroke. Stroke 28:459–463
Gorelick PB, Erkinjuntti T, Hofman A, Rocca WA, Skoog I, Winblad B (1999) Prevention of vascular dementia. Alzheimer Dis Assoc Disorder 13 Suppl 3:131–139
Gottfries CG (1989) Alzheimer’s disease - one, two, or several? J Neural Transm. (P-D Sect) 1:22
Gottfries CG, Nyth AL (1991) Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann NY Acad Sci 640:276–279
Gottfries CG, Blennow K, Karlsson I, Wallin A (1994) The neurochemistry of vascular dementia. 5:163–167
Grayson DA, Henderson AS, Kay DW (1987) Diagnoses of dementia and depression: a latent trait analysis of their performance. Psychol Med 17:667–675
Grohmann R, Schmidt LG, Antretter K, Rüther E (1990) Unerwünschte Wirkungen von Psychopharmaka - ausgewählte Ergebnisse aus dem multizentrischen Zehnjahresprojekt AMÜP. Internist 31:468–474
Gustafson L (1987) Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6:209–233
Hachinski VC, Illif LD, Zilhka E, du Boulay GH, McAllister VL, Marshall J, Russell RWR, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32:632–637
Hachinski VC (1992) Preventable senility: a call for action against the vascular dementias. Lancet 340:645–648
Hampel H, Bürger K, Padberg F, Bahro M (1999) Aktuelle Möglichkeiten und Perspektiven der Liquoruntersuchung bei der Alzheimer Demenz. In: Förstl H, Bickel H, Kurz A (Hrsg) Alzheimer Demenz. Grundlagen, Klinik und Therapie. Springer, Berlin, S 153–166
Hargrave R, Reed B, Mungas D (2000) Depressive syndromes and functional disability in dementia. J Geriatr Psychiatry Neurol 13:72–77
Harrington MG, MacPherson P, McIntosh WB, Allam BF, Bone I (1981) The significance of incidential finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg, Psychiat 44:1168–1170
Haupt M, Kurz A (1990) Die Demenz bei Hypothyreose. Fortschr Neurol Psychiatr 58:175–177
Haupt M, Kurz A, Pollmann S, Romero B (1992) Psychopathologische Störungen bei beginnender Alzheimerscher Krankheit. Fortschr Neurol Psychiatr 60:3–7
Haupt M, Kurz A, Pollmann S, Romero B (1992) Symptomausprägung und Symptomprogression bei Alzheimer-Krankheit - ein Vergleich zwischen Fällen mit frühem und spätem Beginn. Nervenarzt 63:561–565
Haupt M, Janner, Stierstorfer A, Kretschmar C (1998) Klinisches Erscheinungsbild und Stabilität nicht-kognitiver Symptome bei Patienten mit Alzheimer Krankheit. Fortschr Neurol Psychiat 66:233–240
Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF (2000) Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 31:1487–1493
Hennerici MG (1997) Vaskuläre Demenzen. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 309–330
Herholz K (1995) FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 9:6–16
Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF (1998) Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer’s Disease. Neurology 51:159–162
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H (1998) The Bayer Activities of daily living scale (B-ADL). Dement Geriatr Cogn Disord 9 Suppl 2:20–26
Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duijn CN, van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 349:151–154
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RE (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson’s features in Alzheimer’s disease. Neurology 45:1991–1995
Ihl R (1999) Aktueller Stand der Diagnostik-und Therapieleitlinien. In: Müller WE (Hrsg) Dementielle Erkrankungen: Erkennen und behandeln. LinguaMed Verlag, Neu-Isenburg, S 103–124
Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer’s disease, Lewy body disease, vascular lesions. Dementia 6:162–168
Jellinger KA (1989) Morphologie des alternden Gehirns und der (Prä)senilen Demenz. In: Platt D (Hrsg.) Handbuch der Gerontologie, Vol 5. Fischer, Stuttgart, S 3–56
Jellinger KA, Bancher C (1997) Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer’s disease. Neurobiol Aging 18 (Suppl): 55–65
Joachim CL, Morris JH, Selkoe D (1988) Clinically diagnosed Alzheimer’s disease: autopsy neuropathological results in 150 cases. Ann Neurol 24:50–56
Jorm AF (2000) Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 46:219–227
Kanowski S, Ladurner G, Maurer K, Oswald D, Stein U (1990) Empfehlungen zur Evaluierung der Wirksamkeit von Nootropika. Z Gerontopsychol -psychiatrie 3:67–80
Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 60:107–115
Katzman R (1993) Education and the prevalence of dementia and Alzheimer’s disease. Neurology 43:13–20
Katzman R, Brown T, Thal LJ, Fuld PA, Aronson M, Butters N, Klauber MR, Wiederholt W, Pay M, Renbing X, Ooi WL, Hofstetter R, Terry RD (1988) Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s disease. Ann Neurol 24:384–389
Kern U, Menges (1992) Proof of efficacy of nootropics for the indication “dementia”. Phase III recommendations. Pharmacopsychiatry 25:12–135
Kokmen E, Offord K, Okazaki H (1987) A clinical and autopsy study of dementia in Oldsted county, Minnesota, 1980–1981. Neurology 37:426–430
Koponen H, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ (1989) Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 79:579–585
Kral VA (1962) Senescent forgetfullness: benign and malignant. Can Med Ass J 86:257–260
Kratz B, Schröder J, Pantel J, Weimer D, Minnemann E, Lehr O, Sauer H (1998) Leichte kognitive Beeinträchtigung im Alter. Nervenarzt 69:975–982
Ladurner G, Jeindl E, Schneider G (1982) Die Beziehung zwischen multiplen Infarkten and vaskulärer (Multiinfarkt-)Demenz. Fortschr Neurol Psychiat 50:124127
Lang C (1994) Demenzen: Diagnose and Differentialdiagnose. Chapman & Hall, Weinheim
Loeb C (1989) The lacunar syndromes. Eur Neurol 29 Suppl 2:2–7
Loeb C, Gandolfo C, Bino G (1988) Intellectual impairment and cerebral lesions in multiple cerebral infarcts. Stroke 19:560–565
Loeb C, Gandolfo C, Croce R, Conti M (1992) Dementia associated with lacunar infarction. Stroke 23:1225–1229
Mäntylä R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, Standertskjöld-Nordenstam CG (1997) Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke 28:1614–1623
Marsden CD, Harrison MJG (1972) Outcome of investigation of patients with presenile dementia. Br Med J ii:249–252
Martin DC, Miller J, Kapoor W, Arena V, Boller F (1987) A controlled study of survival of patients with dementia. Arch Neurol 44:1122–1126
Martinez-Lage P, Hachinski VC (1999) Vaskulär bedingte kognitive Beeinträchtigung and Demenz. In: Helmchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychische Störungen bei somatischen Krankheiten. Psychiatrie der Gegenwart, 4. Aufl. Springer, Berlin, S 167–204
Mayeux R, Stern Y, Rosen J, Benson DF (1983) Is “subcortical dementia” a recognizable clinical entity? Ann Neurol 14:278–283
McArthur JC, Roos RP, Johnson RT (1993) Viral dementias. In: Whitehouse PJ (ed) Dementia. Davis, Philadelphia, S 237–275
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and human services task force on Alzheimer’s disease. Neurology 34:939–944
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486
Mirra SS (1997) Neuropathological assessment of Alzheimer’s disease: the experience of the Consortium to Establish a Registry for Alzheimer’s Disease. Int Psychogeriatrics 9 Suppl 1:263–268
Mölsa PK, Marttila RJ, Rinne UK (1986) Survival and cause of death in Alzheimer’s disease and multiinfarct dementia. Acta Neurol Scand 74:103–107
Mohs RC, Rosen WG, Davis KL (1983) The Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 19:448450
Müller HF, Schwartz G (1978) Electroencephalograms and autopsy findings in geropsychiatry. J Gerontol 33:504–513
Müller WE, Förstl H (1999) Pharmakologische and nichtmedikamentöse Behandlungsansätze der Demenz. In: Helmchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychische Störungen bei somatischen Krankheiten. Psychiatrie der Gegenwart, 4. Aufl. Springer, Berlin, S 53–70
Mumenthaler M (1987) Behebbare and vermeidbare Demenzen. Schweiz Med Wschr 117:964–967, 1002–1008, 1040–1045
Nagata K, Basugi N, Fukushima T, Tango T, Suzuki I, Kaminuma T, Kurashina S (1987) A quantitative study of physiological cerebral atrophy with aging. Neuroradiology 29:327–332
Neary D, Snowdon JS, Northen B, Goulding P (1988) Dementia of frontal lobe type. J Neurol, Neurosurg, Psychiat 51:351–361
Neary D, Snowdon JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554
Newman SC (1999) The prevalence of depression in Alzheimer’s disease and vascular dementia in a population sample. J Affect Disord 52:169–176
Nolan KA, Lino MM, Seligman AW, Blass JP (1998) Absence of vascular dementia in an autopsy series from a dementia. J Am Geriatr Soc 46:597–604
O’Brien JT, Wolf PA, Bachman DL (1992) Do subjective memory complaints precede dementia? Int J Geriat Psychiatry 7:481–486
O’Connor DW, Politt PA, Hyde JB, Fellows JL, Miller ND, Roth M (1990) A follow-up study of dementia diagnosed in the community using the Cambridge mental disorders of the elderly examination. Acta Psychiat Scand 81:78–82
Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology 51:351–357
Oswald WD, Fleischmann UM (1995) Nürnberger Altersinventar (NAI). Hogrefe, Göttingen
Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam Study 310:970–973
Peters UH (1994) Wörterbuch der Psychiatrie, 3. Aufl. Urban & Schwarzenberg, München
Rabins PV, Folstein MF (1982) Delirium and dementia: diagnostic criteria and fatality rates. Br J Psychiatry 140:149–153
Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for the assessment of primary degenerative dementia. Am J Psychiatry 139:1136–1139
Reisberg B, Schneck MK, Ferris SH, Schwartz GE, deLeon MJ (1983) The brief cognitive rating scale (BCRS). Findings in primary degenerative dementia (PDD). Psychopharmacol Bull 19:47–50
Reisberg B (1988) Functional Assessment Staging (FAST). Psychopharmacol Bull 24:653–659
Reisberg B, Ferris SH, Franssen EH, Shulman E, Monteiro I, Sclan SG, Steinberg G, Kluger A, Torossian C, de Leon MJ, Laska E (1996) Mortality and temporal course of probable Alzheimer’s disease: a 5-year prospective study. Int Psycho-geriatrics 8:291–311
Reynolds CF, Kupfer DJ, Houck PR, Hoch CC, Stack JA, Berman SR, Zimmer B (1988) Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data. Arch Gen Psychiatry 45:258–264
Robertsson B, Blennow K, Gottfries CG, Wallin A (1998) Delirium in dementia. Int J Geriatric Psychiatry 13:49–56
Roman GC (1987) Senile dementia of the Binswanger type. JAMA 258:1782–1788
Ron MA, Toone BK, Garralda ME, Lishman WA (1978) Diagnostic accuracy in presenile dementia. Br J Psychiatry 134:161–168
Rosenquist K, Tariot P, Loy R (2000) Treatments for behavioural and psychological symptoms in Alzheimer’s disease and other dementias. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2ndedn. Arnold, London, S 571–601
Roth M, Tym E, Mountjoy CQ, Huppert PA, Hendrie H, Verma S, Goddard R (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709
Rubin EH, Storandt M, Miller JP, Kinscherf DA, Grant EA, Morris JC, Berg L (1998) A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 55:395–401
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual. DSM-IV, 3. Aufl. Hogrefe, Göttingen
Scheller H (1965) Über den Begriff der Demenz und unterscheidbare klinische Formen von Demenzen. Nervenarzt 36:1–7
Scheltens P, Erkinjuntti T, Leys D, Wahlund LO, Inzitari D, del Ser T, Pasquier F, Barkhof F, Mäntylä R, Bowler J, Wallin A, Ghika J, Fazekas F, Pantoni L (1998) White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 39:80–89
Schmidt R, Fazekas F (1997) Klinische Bedeutung und neuropathologische Basis der „Leuko-Araiose“. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 108–116
Schmitt FA, Davis DG, Wettstein DR, Smith CD, Ashford JW, Markesbery WR (2000) “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology 55:370–376
Schröter J, Pantel J (1999) Morphologische und funktionelle Bildgebung. In: Förstl H, Bickel H, Kurz A (Hrsg) Alzheimer Demenz. Grundlagen, Klinik und Therapie. Springer, Berlin, S 129–152
Smith JS, Kiloh LG (1981) The investigation of dementia: results in 200 consecutive admissions. Lancet i:824–827
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277:813–817
Soares JC, Mann JJ (1997) The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 41:86–106
Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A (2000) Olanzapine treatment of psychotic and behavioral symptoms with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 57:968–976
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL (1987) Anticholinergic sensitivity in patients with dementia of the Alzheimer Type and age-matched controls. Arch Gen Psychiatry 44:418–426
Szelies B, Herholz K, Pawlik G, Karbe H, Hebold I, Heiss W-D (1991) Widespread functional effects of discrete thalamic infarction. Arch Neurol 48:178–182
Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesana-Diaz E (1997) A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer’s disease. Psychosom 38:246–252
Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M (1992) Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42:1185–1193
Taxer F, Haller R, König P (1986) Klinische Frühsymptome and CT-Befunde beim Fahr’schen Syndrom. Nervenarzt 57:583–588
Thal LJ, Grundman M, Klauber MR (1988) Dementia: characteristics of a referral population and factors associated with progression. Neurology 38:1083–1090
Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP (1990) Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci 240:28–33
Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinico-pathologic study of 57 cases. Neurology 38:359–364
Tierney MC, Szalai JP, Snow WG, Fisher RH (1996) The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. Arch Neurol 53:423–427
Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:331–356
Ulrich J, Probst A, West M (1986) The brain diseases causing senile dementia. J Neurol 233:118–122
Unkenstein A (2000) Psychological approaches for the management of cognitive impairment in Alzheimer’s disease. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2ndedn. Arnold, London, S 615–620
Wetterling T (1992) Neurotransmitter-Veränderungen bei der Demenz vom Alzheimer Typ. Nervenheilkunde 11:239–245
Wetterling T (1992) Subkortikale arteriosklerotische Enzephalopathie - eine Krankheitsentität? Nervenheilkunde 11:289–293
Wetterling T (1994) Differentialdiagnose dementieller Abbauprozesse. Thieme, Stuttgart
Wetterling T (1996) Therapeutische Strategien bei vaskulärer Demenz. Fortschr Med 114:445–450
Wetterling T (1997) Depressive Pseudodemenz. In: Radebold H, Hirsch D, Kipp J, Kortus R, Stoppe G, Struwe B, Wächtler C (Hrsg) Depression im Alter. Steinkopff, Darmstadt, S 92–95
Wetterling T (1998) Vaskuläre Demenz - ein schlüssiges Konzept? Z Gerontol Geriatr 31:36–45
Wetterling T (2001) Gerontopsychiatrie. Ein Leitfaden für Diagnostik und Therapie. Springer, Berlin
Wetterling T, Rama B (1989) Zur Differentialdiagnose von subduralen Effusionen. Röntgen-B1 42:508–514
Wetterling T, Borgis K-J (1992) Klinisch-diagnostische Einordnung von Patienten mit Marklager-Hypodensitäten. Nervenheilkunde 11:294–298
Wetterling T, Kanitz R-D, Borgis K-J (1996) Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 27:30–36
Wetterling T, Schürmann A (1997) Gründe für die Heimeinweisung stationär aufgenommener gerontopsychiatrischer Patienten. Z Gerontol Geriatr 30:469–473
Wetterling T, Junghanns K (2000) Psychiatrischer Konsiliardienst bei älteren Patienten. Nervenarzt 71:559–564
Weytingh MD, Bossuyt PM, van Crevel H (1995) Reversible dementia: more than 10% or less than 1%: a quantitative review. J Neurol 242:466–471
Whitehouse PJ (1986) The concept of subcortical and cortical dementia: another look. Ann Neurol 19:1–6
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 146:577–587
Zaudig M, Mittelhammer J, Hiller W (1989) SIDAM. Strukturiertes Interview für die Diagnose der Demenz vom Alzheimer Typ, der Multiinfarkt-Demenz und Demenzen anderer Ätiologien nach DSM-III-R und ICD-10. Logomed Verlag, München
BGA (1991) Gemeinsames Papier der das Bundesgesundheitsamt beratenden Zulassungskommissionen für neue Stoffe (Kommission A) und der Aufbereitungskommission „Neurologie, Psychiatrie“ (Kommission B3). Empfehlung zum Wirksamkeitsnachweis von Nootropika im Indikationsbereich „Demenz” (Phase III). Bundesgesundhbl 7:342–350
Literatur
Aarsland D, Larsen JP, Waage O, Langeveld JH (1997) Maintenance electroconvulsive therapy for Parkinson’s disease. Convuls Ther 13:274–277
Adams SG Jr, Dammers PM, Saia TL, Brantley PJ, Gaydos GR (1994) Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. J Behav Med 17:459–477
Aikens JE, Reinecke MA, Pliskin NH, Fischer JS, Wiebe JS, McCracken LM, Taylor JL (1999) Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory? J Behav Med 22:127–142
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia. Biol Psychiatry 23:271–284
Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) Vascular depression’ hypothesis. Arch Gen Psychiatry 54:915–922
Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M (1997) Clinically defined vascular depression. Am J Psychiatry 154:562–565
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM IV). American Psychiatric Association, Washington DC, S 165–174
American Psychiatric Association (1997) Practice guidelines for the treatment of patients with Alzheimer’s disease and other dementias of late life. Am J Psychiatry 154, Suppl 5:1–39
Andersen K, Balldin J, Gottfries CG, Granerus AK, Modigh K, Svennerholm L, Wallin A (1987) A double-blind evaluation of electroconvulsive therapy in Parkinson’s disease with `on-off’-phenomena. Acta Neurol Scand 76:191–199
Angst J, Dobler-Mikola A (1986) Assoziation von Angst and Depression auf syndromaler and diagnostischer Ebene. In: Heimchen H, Linden M (Hrsg) Die Differenzierung von Angst and Depression. Springer, Berlin, S 75–82
Angst J, Vollrath M (1989) Beziehungen zwischen Angst and Depression. In: Kielholz P, Adams C (Hrsg) Die Vielfalt von Angstzuständen. Deutscher Ärzte-Verlag, Köln, S 79–100
Arzneimittel-VerlagsGmbH (1999) Arzneimittelkursbuch 99/2000. Berlin
Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, Kinkel PR (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 11:1153–1158
Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan V, Dubey N, Kinkel PR (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6:181–185
Baldwin R (1997) Depressive Erkrankungen. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 408–418
Ballard C, McKeith I, O’Brien J, Kalaria R, Jaros E, Ince P, Perry R (2000) Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 11:59–65
Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R (2000) Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59:97–106
Barbui C, Hotopf M (2001) Amitriptyline vs. the rest: still the leading antidepressant after 40 years of randomized trials. Br J Psychiatry 178:129–144
Barry JJ, Huynh N, Lembke A (2000) Depression in individuals with epilepsy. Curr Treat Options Neurol 2:571–585
Baumgartner A (1993) Schilddrüsenhormone and depressive Erkrankungen - kritische Übersicht and Perspektiven. Teil I: Klinik. Nervenarzt 64:1–10
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psych 4:561–571 (deutsch: Hogrefe Testzentrale, Göttingen)
Benkert O, Hippius H (2000) Kompendium der Psychiatrischen Pharmakotherapie, 2. Aufl. Springer, Berlin
Berg D, Supprian T, Thomae J, Warmuth-Metz M, Horowski A, Zeiler B, Magnus T, Rieckmann P, Becker G (2000) Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 6:156–162
Berthier ML, Kulisevsky J, Gironell A, Fernandez Benitez JA (1996) Poststroke bipolar affective disorder: clinical subtypes, concurrent movement disorders, and anatomical correlates. J Neuropsychiatry Clin Neurosci 8:160–167
Blanchet P, Frommer GP (1986) Mood change predicting epileptic seizures. J Nery Ment Dis 174:364–372
Bron B (1990) Alterstypische psychopathologische Besonderheiten bei endogenen and neurotisch-reaktiven Depressionen im höheren Lebensalter. Nervenarzt 61:170–175
Brownlie BE, Rae AM, Walshe JW, Wells JE (2000) Psychoses associated with thyrotoxicosis - `thyrotoxic psychosis’. A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 142:438–444
Buntinx F, Kester A, Bergers J, Knottnerus JA (1996) Is depression in elderly people followed by dementia? Age Aging 25:231–233
Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M (2000) Depression after stroke and lesion location: a systematic review. Lancet 356 (9224):122–126
Christensen H, Griffith K, Mackinnon A, Jacomb P (1997) A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 3:631–651
Conwell Y, Henderson RE (1996) Neuropsychiatry of suicide. In: Fogel BS, Schiffer RB, Rao SM (Hrsg) Neuropsychiatry. Williams & Wilkins, Baltimore, S 485–521
Copeland JRM, Dewey ME (1985) Differential diagnosis: depression versus dementia. In: Traber J, Gispen WH (eds) Senile dementia of the Alzheimer type. Springer, Berlin, S 72–83
Copeland JRM, Davidson IA, Dewey ME, Larkin BA, McWilliam C, Saunders PA, Scott LR, Sharma V, Sullivan C (1992) Alzheimer’s disease, other dementias, depression and pseudodementia: Prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 161:230–239
Cummings JL (1986) Subcortical dementia. Neuropsychology, neuropsychiatry, and pathopsychology. Br J Psychiatry 149:682–689
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454
Cummings JL, Miller B, Hill MA, Neshkes R (1987) Delusions, depression, and hallucinations were assessed in 30 patients with dementia of the Alzheimer type (DAT) and 15 with multi-infarct dementia. Arch Neurol 44:389–393
Curry SL, Levine SB, Corty E, Jones PK, Kurit DM (1994) The impact of systemic lupus erythematosus on women’s sexual functioning. J Rheumatol 21:2254–2260
Da Costa D, Dobkin PL, Pinard L, Fortin PR, Danoff DS, Esdaile JM, Clarke AE (1999) The role of stress in functional disability among women with systemic lupus erythematosus: a prospective study. Arthritis Care Res 12:112–119
De Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM (2000) Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 57:1071–1076
Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R (1996) Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 53:175–182
Dickson CJ (1997) Chronic fatigue syndrome - aetiological aspects. Eur J Clin Invest 27:257–267
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien. 3. Aufl. Huber, Bern
Douyon R, Serby M, Klutchko B, Rotrosen J (1989) ECT and Parkinson’s disease revisited: a “naturalistic” study. Am J Psychiatry 146:1451–1455
Downing RW, Rickels K (1974) Mixed anxiety-depression: fact or myth? Arch Gen Psychiatry 30:312–317
Draper B, MacCuspie-Moore C, Brodaty H (1998) Suicidal ideation and the `wish to die’ in dementia patients: the role of depression. Age Ageing 27:503–507
Driessen M, Wetterling T, Wedel T, Preuss R (1995) Secondary hyperparathyroidism and depression in chronic renal failure. Nephron 70:334–339
Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC, Menolascino FJ, Muller DJ (1992) Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 53, Suppl 2:57–60
Eastwood MR, Rifat SL, Nobbs H, Ruderman J (1989) Mood disorder following cerebrovascular accident. Br J Psychiatry 154:195–200
Eiber R, Berlin I, Grimaldi A, Bisserbe JC (1997) Diabete insulinodependent et pathologie psychiatrique: revue generale clinique et epidemiologique. Encephale 23:351–357
Fairweather DB, Kerr JS, Harrison DA, Moon CA, Hindmarch I (1993) A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 8:41–47
Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151:1571–1583
Fann JR, Katon WJ, Uomoto JM, Esselman PC (1995) Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry 152:1493–1499
Fedoroff JP, Starkstein SE, Forrester AW, Geisler F, Jorge RE, Robinson RG (1992) Depression in patients with acute brain injury. Am J Psychiatry 149:7
Feinstein A (1995) Depression associated with multiple sclerosis: an etiological conundrum. Can J Psychiatry 40:573–576
Feinstein A, Feinstein K, Gray T, O’Connor P (1997) Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54:1116–1121
Feinstein A, O’Connor P, Gray T, Feinstein K (1999) Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex. Mult Scler 5:69–73
Feinstein A, O’Connor P, Gray T, Feinstein K (1999) The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 5:323–326
Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14:220–223
Fichter MM, Witzke W (1990) Affektive Erkrankungen. In: Fichter MM (Hrsg) Verlauf psychischer Erkrankungen in der Bevölkerung. Springer, Berlin, S 112–144
Fishbein DA (1996) Pain and psychopathology. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 443–483
Fisk JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ (1998) Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 25:230–235
Flint AJ (1998) Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents. Drugs Aging 13:269–280
Förstl H, Burns A, Cairns N, Luthert P, Lantos P, Levy R (1992) Organische Grundlagen depressiver Symptome bei Alzheimer Demenz. Nervenarzt 63:566–574
Folstein S (1989) Huntington’s disease: a disorder of families. John Hopkins Press, Baltimore
Ford H, Trigwell P, Johnson M (1998) The nature of fatigue in multiple sclerosis. J Psychosom Res 45 (1 Spec No):33–38
Forsell Y, Winblad B (1998) Major depression in a population of demented and nondemented older people: prevalence and correlates. J Am Geriatr Soc 46:27–30
Fritze J, Deckert J, Lanczik M, Strik W, Struck M, Wodarz N (1992) Zum Stand der Aminhypothesen depressiver Erkrankungen. Nervenarzt 63:3–13
Frühwald S, Löffler H, Baumhackl U (1999) Depressionen nach zerebrovaskulären Ereignissen. Überblick und Abgrenzung von anderen psychiatrischen Komplikationen. Fortschr Neurol Psychiatr 67:155–162
Garden FH, Garrison SJ, Jain A (1990) Assessing suicide risk in stroke patients: review of two cases. Arch Phys Md Rehabil 71:1003–1005
Gill D, Hatcher S (2000) Antidepressants for depression in people with physical illness (Cochrane Review). Cochrane Database Syst Rev 4:CD001312
Gjerris A, Werdelin L, Gjerris F, Sörensen PS, Rafaelsen OJ, Alling C (1987) CSFamine metabolites in depression, dementia and in controls. Acta Psychiatr Scand 75:619–628
Gottfries CG, Nyth AL (1991) Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia. Ann NY Acad Sci 640:276–279
Green AI, Austin CP (1993) Psychopathology of pancreatic cancer. A psychobiologic probe. Psychosomatics 34:208–221
Grohmann R, Schmidt LG, Antretter K, Rüther E (1990) Unerwünschte Wirkungen von Psychopharmaka - ausgewählte Ergebnisse aus dem multizentrischen Zehnjahresprojekt AMÜP. Internist 31:468–474
Haggerty JJ, Golden RN, Evans DL, Janowsky DS (1988) Differential diagnosis of pseudodementia in the elderly. Geriatrics 43:61–74
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62 (deutsch: Hogrefe Testzentrale, Göttingen)
Hargrave R, Reed B, Mungas D (2000) Depressive syndromes and functional disability in dementia. J Geriatr Psychiatry Neurol 13:72–77
Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF (2000) Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 31:1487–1493
Heuser I, Möller AA (1992) Depression. In: Möller AA, Fröscher W (Hrsg) Psychische Störungen bei Epilepsie. Thieme, Stuttgart, S 37–44
Hirschfeld RM (1999) Efficacy of SSRIs and newer antidepressants inseveredepression: comparison with TCAs. J Clin Psychiatry 60:326–335
Hüwel J, Weisner B, Kemmer H, Heyder J (1998) Depressive Verstimmung im Akutstadium nach erstmaligem ischämischen Hirninfarkt. Nervenarzt 69:330–334
Inskip HM, Harris EC, Barraclough B (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 172:35–37
Isacsson G, Holmgren P, Wasserman D, Bergman U (1994) Use of antidepressants among people committing suicide in Sweden. BMJ 308 (6927):506–509
Jick SS, Dean AD, Jick H (1995) Antidepressants and suicide. BMJ 310 (6974): 215–218
Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44:376–378
Jorge RE, Robinson RG, Starkstein SE, Arndt SV (1993) Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci 5:369–374
Jorm AF (2000) Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 46:219–227
Kanowski S (1996) Das depressive Syndrom. In: Zapotoczky HG, Fischhof PK (Hrsg) Handbuch der Gerontopsychiatrie. Springer, Wien, S 144–147
Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. QJM 89:543–551
Ketter TA, Post RM, Theodore WH (1999) Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 53 (5 Suppl 2):53–67
Kishi Y, Kosier JT, Robinson RG (1996) Suicidal plans in patients with acute stroke. J Nery Ment Dis 184:274–280.
Kivelä S-L, Pahkala K (1988) Symptoms of depression in old people in Finland. Z Gerontol 21:257–263
Kral V (1982) Depressive Pseudodemenz and senile Demenz vom Alzheimer Typ. Nervenarzt 53:284–286
Krishnan KR (2000) Depression as a contributing factor in cerebrovascular disease. Am Heart J 140 (Suppl):70–76
Krishnan KR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154:497–501
Köbberling J, Hintze G, Blossey HC, Dirks H, Emrich D, Mayer G, Schicha H (1981) Diagnostische Probleme der Hyperthyreose im höheren Lebensalter. DMW 106:973–978
Kroencke DC, Lynch SG, Denney DR (2000) Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler 6:131–136
Kurlan R, Caine E, Rubin A, Nemeroff CB, Bissette G, Zaczek R, Coyle J, Spielman FJ, Irvine C, Shoulson I (1988) Cerebrospinal fluid correlates of depression in Huntington’s disease. Arch Neurol 45:881–883
Lambert MV, Robertson MM (1999) Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 40, Suppl 10:21–47
Larcombe NA, Wilson PH (1984) An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry 145:366–371
Lasar M, Kotterba S (1997) Bewältigungsstile and kognitive Einstellungen bei Patienten mit Multipler Sklerose. Wien Klin Wochenschr 109:954–959
Laux G (2001) Cost-benefit analysis of newer versus older antidepressants. Pharmacopsychiatry 34:1–5
Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M (1994) Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry 51:677–686
Lipe H, Schultz A, Bird TD (1993) Risk factors for suicide in Huntington’s disease: a retrospective case controlled study. Am J Med Genet 48:231–233
Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303–1307
Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198
Lyness JM, Caine ED, King DA, Conwell Y, Cox C, Duberstein PR (1999) Cerebrovascular risk factors and depression in older primary care patients: testing a vascular brain disease model of depression. Am J Geriatr Psychiatry 7:252–258
Lyness JM, King DA, Conwell Y, Cox C, Caine ED (2000) Cerebrovascular risk factors and 1-year depression outcome in older primary care patients. Am J Psychiatry 157:1499–1501
Masson F, Maurette P, Salmi LR, Dartigues JF, Vecsey J, Destaillats JM, Erny P (1996) Prevalence of impairments 5 years after a head injury, and their relationship with disabilities and outcome. Brain Inj 10:487–497
Mattson D, Petrie M, Srivastava DK, McDermott M (1995) Multiple sclerosis. Sexual dysfunction and its response to medications. Arch Neurol 52:862–868
Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE (1992) Paralimbic frontal lobe hypometabolism in depression associated with Hunting-ton’s disease. Neurology 42:1791–1797
Meyer C, Rumpf H-J, Hapke U, Dilling H, John U (2000) Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung. Nervenarzt 71:535–542
Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A (1994) Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 89:117–121
Mohr DC, Goodkin DE, Gatto N, Van der Wende J (1997) Depression, coping and level of neurological impairment in multiple sclerosis. Mult Scler 3:254–258
Mohr DC, Goodkin DE, Likosky W, Beutler L, Gatto N, Langan MK (1997) Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med 20:407–414
Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, Van der Wende J, Dwyer P, Dick LP (2000) Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 68:356–361
Montgomery SA (1997) Suicide and antidepressants. Ann NY Acad Sci 836:329338
Müller-Siecheneder F, Müller MJ, Hillert A, Szegedi A, Wetzel H, Benkert 0 (1998) Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 18:111–120
Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS (1998) Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. J Neuropsychiatry Clin Neurosci 10:453–455
Natelson BH, LaManca JJ, Denny TN, Vladutiu A, Oleske J, Hill N, Bergen MT, Korn L, Hay J (1998) Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 105:43–49
Neau JP, Ingrand P, Mouille-Brachet C, Rosier MP, Couderq C, Alvarez A, Gil R (1998) Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 8:296–302
Nebes RD, Pollock BG, Mulsant BH, Butters MA, Zmuda MD, Reynolds CF 3rd(1999) Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry 60 Suppl 20:26–29
Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS, Robin DW, Gergel I, McCafferty J, Roose S (1999) Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 156:1024–1028
Newman SC (1999) The prevalence of depression in Alzheimer’s disease and vascular dementia in a population sample. J Affect Disord 52:169–176
Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I (1995) A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 36:390–395
Nyenhuis DL, Rao SM, Zajecka JM, Luchetta T, Bernardin L, Garron DC (1995) Mood disturbance versus other symptoms of depression in multiple sclerosis. J Int Neuropsychol Soc 1:291–296
O’Brien JT, Metcalfe S, Swann A, Hobson J, Jobst K, Ballard C, McKeith I, Gholkar A (2000) Medial temporal lobe width on CT scanning in Alzheimer’s disease: comparison with vascular dementia, depression and dementia with Lewy bodies. Dement Geriatr Cogn Disord 11:114–118
O’Brien JT, Perry R, Barber R, Gholkar A, Thomas A (2000) The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann NY Acad Sci 903:482–489
Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR (1990) The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 47:785–789
Passik SD, Breitbart WS (1996) Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 78 (3 Suppl):615–626
Patten SB, Metz LM (1997) Depression in multiple sclerosis. Psychother Psychosom 66:286–292
Patten SB, Metz LM, Reimer MA (2000) Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 6:115–120
Paykel ES (1971) Classification of depressed patients: a cluster analysis derived grouping. Br J Psychiatry 118:275–288
Pisani F, Spina E, Oteri G (1999) Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40, Suppl 10:48–56
Poewe W, Luginger E (1999) Depression in Parkinson’s disease: impediments to recognition and treatment options. Neurology 52 (7 Suppl 3):2–6
Prusoff BA, Klerman GL (1974) Differentiating depressed from anxious neurotic outpatients. Arch Gen Psychiatry 30:302–308
Rabins PV, Merchant A, Nestadt G (1984) Criteria for diagnosing reversible dementia caused by depression: validation by 2-year follow-up. Br J Psychiatry 144:488–492
Ranen NG, Peyser CE, Folstein SE (1994) ECT as a treatment for depression in Huntington’s disease. J Neuropsychiatry Clin Neurosci 6:154–159
Rao R (2000) Cerebrovascular disease and late life depression: an age old association revisited. Int J Geriatr Psychiatry 15:419–433
Rao V, Lyketsos CG (2000) The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Geriatr Psychiatry 15:729735
Rasmussen K, Abrams R (1991) Treatment of Parkinson’s disease with electroconvulsive therapy. Psychiatr Clin North Am 14:925–933
Reifler BV, Larson E, Teri L, Poulsen M (1986) Dementia of Alzheimer’s disease and depression. J Am Geriatr Soc 34:855–859
Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P (1989) Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression. Am J Psychiatry 146:45–49
Reynolds CF, Kupfer DJ, Houck PR, Hoch CC, Stack JA, Berman SR, Zimmer B (1988) Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data. Arch Gen Psychiatry 45:258–264
Richard IH (2000) Depression in Parkinson’s disease. Curr Treat Options Neurol 2:263–274
Rink HA, Trimble MR (1990) Depression in epilepsy. In: Starkstein SE, Robinson RG (eds) Depression in Neurological Disease. Johns Hoppkins University Press, S 63–83
Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993) Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study. Am J Psychiatry 150:286–293
Robinson RG, Travella JI (1996) Neuropsychiatry of mood disorders. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 279–305
Roth M, Gurney C, Garside RF, Kerr TA (1972) The relationship between anxiety states and depressive illnesses. Part I. Br J Psychiatry 121:147–161
Sachdev PS, Smith JS, Angus Lepan H, Rodriguez P (1990) Pseudodementia twelve years on. J Neurol Neurosurg Psychiatry 53:254–259
Sackeim HA, Prohovnik I, Moeller JR, Brown RP, Apter S, Prudic J, Devanand DP, Mukherjee S (1990) Regional cerebral blood flow in mood disorders. 1. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry 47:60–70
Salmaggi A, Palumbo R, Fontanillas L, Eoli M, La Mantia L, Solari A, Pareyson D, Milanese C (1998) Affective disorders and multiple sclerosis: a controlled study on 65 Italian patients. Ital J Neurol Sci 19:171–175
Sano M, Stern Y, Williams J, Cote L, Rosenstein R, Mayeux R (1989) Coexisting dementia and depression in Parkinson’s disease. Arch Neurol 46:1284–1286
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches and statistisches Manual psychischer Störungen, DSM-IV, 3. Aufl. Hogrefe, Göttingen
Schildkraut J (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509
Schiaffino KM, Shawaryn MA, Blum D (1998) Examining the impact of illness representations on psychological adjustment to chronic illnesses. Health Psychol 17:262–268
Schiffer RB, Hernden RM, Rudick RA (1985) Treatment of pathological laughing and weeping with amitriptyline. N Engl J Med 312:1480–1482
Schmidt R, Fazekas F (1997) Klinische Bedeutung and neuropathologische Basis der „Leuko-Araiose“. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 108–116
Shiwach R (1994) Psychopathology in Huntington’s disease patients. Acta Psychiatr Scand 90:241–246
Shnek ZM, Foley FW, LaRocca NG, Gordon WA, DeLuca J, Schwartzman HG, Halper J, Lennox S, Irvine J (1997) Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 19:287–294
Shortall E, Isenberg D, Newman SP (1995) Factors associated with mood and mood disorders in SLE. Lupus 4:272–279
Silfverskiöld P, Risberg J (1989) Regional cerebral blood flow in depression and mania. Arch Gen Psychiatry 46:253–259
Silver JM, Hales RE, Yudofsky SC (1994) Neuropsychiatric aspects of traumatic brain injury. In: Yudofsky SC, Hales RE (eds) Synopsis of neuropsychiatry. American Psychiatric Press, Washington DC, S 280–306
Simpson S, Allen H, Temenson B, Burns A (1999) Neurological correlates of depressive symptoms in Alzheimer’s disease and vascular dementia. J Affect Disord 53:129–136
Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H (1986) Post-stroke depression: relationship to functional impairment, coping strategies, and rehabilitation outcome. Stroke 17:1102–1107
Smith SJ, Young CA (2000) The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 14:50–54
Soares JC, Mann JJ (1997) The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry 41:86–106
Starcevic V (1999) Neurasthenia: cross-cultural and conceptual issues in relation to chronic fatigue syndrome. Gen Hosp Psychiatry 21:249–255
Starkstein SE, Robinson RG (1989) Affective disorders and cerebral vascular disease. Br J Psychiatry 154:170–182
Starkstein SE, Petracca G, Chemerinski E, Teson A, Sabe L, Merello M, Leiguarda R (1998) Depression in classic versus akinetic-rigid Parkinson’s disease. Mov Disord 13:29–33
Stavrakaki C, Vargo B (1986) The relationship of anxiety and depression: a review of the literature. Br J Psychiatry 149:7–16
Steller U, Schulz-Venrath U (1995) Zerebrovaskuläre Erkrankungen. In: Ahrens S, Hasenbring M, Schulz-Venrath U, Strenge H (Hrsg) Psychosomatik in der Neurologie. Schattauer, Stuttgart, S 152–178
Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303
Stenager EN, Koch-Henriksen N, Stenager E (1996) Risk factors for suicide in multiple sclerosis. Psychother Psychosom 65:86–90
Sullivan MJ, Weinshenker B, Mikail S, Bishop SR (1995) Screening for major depression in the early stages of multiple sclerosis. Can J Neurol Sci 22:228–231
Sullivan MJ, Weinshenker B, Mikail S, Edgley K (1995) Depression before and after diagnosis of multiple sclerosis. Mult Scler 1:104–108
Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA, Murphy DL (1987) Anticholinergic sensitivity in patients with dementia of the Alzheimer Type and age-matched controls. Arch Gen Psychiatry 44:418–426
Swartz M, Barak Y, Mirecki I, Naor S, Weizman A (2000) Treating depression in Alzheimer’s disease: integration of differing guidelines. Int Psychogeriatr 12:353358
Teri L, Logsdon RG, Uomoto J, McCurry SM (1997) Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol Series B 52: P159–166
Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875–882
Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP (1990) Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci 240:28–33
Thomas AJ, Ferrier IN, Kalaria RN, Woodward SA, Ballard C, Oakley A, Perry RH, O’Brien JT (2000) Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 157: 1682–1684
Thomas FJ, Wiles CM (1999) Dysphagia and nutritional status in multiple sclerosis. J Neurol 246:677–682
Tom T, Cummings JL (1998) Depression in Parkinson’s disease: pharmacological characteristics and treatment. Drugs Ageing 12:55–76
Van Valkenburg C, Akiskal HS, Puzantian V, Rosenthal T (1984) Anxious depressions: clinical, family history, and naturalistic outcome - comparisons with panic and major depressive disorders. J Affect Dis 6:67–82
Ward MM, Lotstein DS, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM (1999) Psychosocial correlates of morbidity in women with systemic lupus erythematosus. J Rheumatol 26:2153–2158
Wengel SP, Burke WJ, Pfeiffer RF, Roccaforte WH, Paige SR (1998) Maintenance electroconvulsive therapy for intractable Parkinson’s disease. Am J Geriatr Psychiatry 6:263–269
Wetterling T (1992) Neurotransmitter-Veränderungen bei der Demenz vom Alzheimer Typ. Nervenheilkunde 11:239–245
Wetterling T (1992) Subkortikale arteriosklerotische Enzephalopathie - eine Krankheitsentität? Nervenheilkunde 11:289–293
Wetterling T (1994) Differentialdiagnose dementieller Abbauprozesse. Thieme, Stuttgart
Wetterling T (1997) Depressive Pseudodemenz. In: Radebold H, Hirsch D, Kipp J, Kortus R, Stoppe G, Struwe B, Wächtler C (Hrsg) Depression im Alter. Steinkopff, Darmstadt, S 92–95
Wetterling T (1998) Besonderheiten affektiver Psychosen im Alter. In: Hartwich P, Haas S, Maurer K, Pflug B (Hrsg) Affektive Störungen und Lebensalter. Verlag Wissenschaft und Praxis, Sternenfels, S 29–38
Wetterling T (1998) Vascular depression - a concise concept? Eur Psychiatry 13 Suppl 4:167
Wetterling T (1999) Diagnostik und Behandlungsansätze depressiver Störungen bei Alkoholabhängigen. Fortschr Neurol Psychiat 67:131–141
Wetterling T (1999) Vaskuläre Depression - ein schlüssiges Konzept? Fortschr Neurol Psychiat 67:327–335
Wetterling T (2000) Psychopathologische Aspekte zur Diagnostik und Verlaufsmessung von Angststörungen im Alter. In: Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G, Wächtler C (Hrsg) Angst-Sucht-Anpassungsstörungen im Alter. Schriftenreihe der Deutschen Gesellschaft für Gerontopsychiatrie und Psychotherapie, Band 1, Düsseldorf, S 105–109
Wetterling T, Reger K-H, Borgis K-J (1993) Symptomatische Behandlung von gerontopsychiatrischen Patienten mit einer Leuko-Araiosis im CT. In: Möller H-J, Rohde A (Hrsg) Psychische Krankheiten im Alter. Springer, Berlin, S 216–217
Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R (1999) Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 47:211–217
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 146:577–587
Zerfaß R, Kretschmar K, Förstl H (1992) Depressive Störungen nach Hirninfarkt: Beziehungen zu Infarktlage, Hirnatrophie und kognitiven Defiziten. Nervenarzt 63:163–168
Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G (1999) Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 5:428–431
Zubenko GS, Moosy J, Kopp U (1990) Neurochemical correlates of major depression in primary dementia. Arch Neurol 47:209–214
Literatur
Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 152:1130–1138
Bakchine S, Lacomblez L, Benoit N, Parisot D, Chain F, Lhermitte F (1989) Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine. Neurology 39:777–781
Barczak P, Edmunds E, Betts T (1988) Hypomania following complex partial seizures. A report of three cases. Br J Psychiatry 152:137–139
Bazire S (2000) Psychotropic drug directory 2000. Mark Allen Publishing, Wilts
Bech P, Kastrup M, Rafaelsen OJ (1991) Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM III syndromes. Acta Psychiatr Scand 326 (Suppl):1–37 (deutsch: LIPS 4. Aufl., Beltz Test, Weinheim)
Berk M, Ichim L, Brook S (1999) Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 14:339–343
Berthier ML, Kulisevsky J, Gironell A, Fernandez Benitez JA (1996) Poststroke bipolar affective disorder: clinical subtypes, concurrent movement disorders, and anatomical correlates. J Neuropsychiatry Clin Neurosci 8:160–167
Brownlie BE, Rae AM, Walshe JW, Wells JE (2000) Psychoses associated with thyrotoxicosis - `thyrotoxic psychosis’. A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 142(5):438–444
Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. III: Disorders of mood. Br J Psychiatry 157:81–86, 92–94
Cummings JL (1991) Behavioral complications of drug treatment of Parkinson’s disease. J Am Geriatr Soc 39:708–716
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Dupont RM, Butters N, Schafer K, Wilson T, Hesselink J, Gillin JC (1995) Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 38:482–486
El-Mallakh RS (1991) Mania in AIDS: clinical significance and theoretical considerations. Int J Psychiatry Med 21:383–391
Evans DL, Byerly MJ, Greer RA (1995) Secondary mania: diagnosis and treatment. J Clin Psychiatry 56, Suppl 3:31–37
Faust V (1997) Manie. Enke, Stuttgart
Fahim S, van Duijn CM, Baker FM, Launer L, Breteler MM, Schudel WJ, Hofman A (1998) A study of familial aggregation of depression, dementia and Parkinson’s disease. Eur J Epidemiol 14:233–238
Fenn D, George K (1999) Post-stroke mania late in life involving the left hemisphere. Aust N Z J Psychiatry 33:598–600
Fisk JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ (1998) Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 25:230–235
Fujikawa T, Yamawaki S, Touhouda Y (1995) Silent cerebral infarctions in patients with late-onset mania. Stroke 26:946–949
Garfield DA (1985) Multiple sclerosis and affective disorder: 2 case reports of mania with psychosis. Psychother Psychosom 44:25–33
Ghika-Schmid F, Bogousslaysky J (1997) Affective disorders following stroke. Eur Neurol 38:75–81
Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affect Dis 43:151–161
Harper PS (1991) Huntington’s disease. In: Detchant W, Warlow CP (eds) Major problems in neurology, Vol. 22. Saunders, London
Hoffman BF (1982) Reversible neurosyphilis presenting as chronic mania. J Clin Psychiatry 43:338–339
Kellner CH, Davenport Y, Post RM, Ross RJ (1984) Rapidly cycling bipolar disorder and multiple sclerosis. Am J Psychiatry 141:112–113
Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. QJM 89:543–551
Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Personal and family history of affective illness in patients with multiple sclerosis. J Affect Disord 12:6365
Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Mood disorder and multiple sclerosis. Arch Neurol 44:376–378
Jorge RE, Robinson RG, Starkstein SE, Arndt SV (1993) Manic syndromes following traumatic brain injury. Am J Psychiatry 150:916–921
Kim E, Zwil AS, McAllister TW, Glosser DS, Stern M, Hurtig H (1994) Treatment of organic bipolar mood disorders in Parkinson’s disease. J Neuropsychiatry Clin 6:181–184
Liu CY, Wang SJ, Fuh JL, Yang YY, Liu HC (1996) Bipolar disorder following a stroke involving the left hemisphere. Aust N Z J Psychiatry 30:688–691
Lyketsos CG, Corazzini K, Steele C (1995) Mania in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 7:350–352
Minden SL, Orav J, Schildkraut JJ (1988) Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38:1631–1634
Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 47:98–104
Moskowitz AS, Altshuler L (1991) Increased sensitivity to lithium-induced neurotoxicity after’stroke: a case report. J Clin Psychopharmacol 11:272–273
Pine DS, Douglas CJ, Charles E, Davies M, Kahn D (1995) Patients with multiple sclerosis presenting to psychiatric hospitals. J Clin Psychiatry 56:297–306
Ritter G, Prange HW (1987) Klinik, Diagnostik and Therapie der Neurosyphilis. Nervenarzt 58:265–271
Robinson RG, Boston JD, Starkstein SE, Price TR (1988) Comparison of mania with depression following brain injury. Am J Psychiatry 145:172–178
Robinson RG, Travella JI (1996) Neuropsychiatry of mood disorders. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 279–305
Rundell JR, Wise MG (1989) Causes of organic mood disorder. J Neuropsychiatry Clin Neurosci 1:398–400
Schiffer RB, Wineman NM, Weitkamp LR (1986) Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 143:94–95
Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S (1988) Multiple sclerosis and affective disorder. Family history, sex, and HLA-DR antigens. Arch Neurol 45:1345–1348
Schifferdecker M, Krahl A, Krekel NO (1995) Psychosen bei multipler Sklerose - eine Neubewertung. Fortschr Neurol Psychiatr 63:310–319
Segal J, Berk M, Brook S (1998) Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21:176–180
Shukla S, Cook BI, Mukherjee S (1987) Mania following head trauma. Am J Psychiatry 144:93–96
Starkstein SE, Boston JD, Robinson RG (1988) Mechanisms of mania after brain injury. 12 case reports and review of the literature. J Nery Ment Dis 176:87–100
Starkstein SE, Pearlson GD, Robinson RG (1988) Mania after brain injury: a controlled study of etiological factors. Arch Neurol 44:1069–1073
Starkstein SE, Federoff JP, Berthier ML, Robinson RG (1991) Manic depressive and pure manic states after brain lesions. Biol Psychiatry 29:149–158
Starkstein SE, Robinson RG (1997) Mechanism of disinhibition after brain lesions. J Nery Ment Dis 185:108–114
Steffens DC, Krishnan KR (1998) Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 43:705–712
Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V (1999) Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702–709
Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57:841–849
Turecki G, Mari JD, Del Porto JA (1993) Bipolar disorder following a left basal-ganglia stroke. Br J Psychiatry 163:690
Winokur G, Coreyll W, Akiskal HS, Maser JD, Keller MB, Endicott J, Mueller T (1995) Alcoholism in manic-depressive (bipolar) illness. Familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry 152:365–372
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Literatur
Aarsland D, Larsen JP, Cummings JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56:595–601
Adams SG Jr, Dammers PM, Saia TL, Brantley PJ, Gaydos GR (1994) Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in systemic lupus erythematosus. J Behav Med 17:459–477
Aharon-Peretz J, Kliot D, Tomer R (2000) Behavioral differences between white matter lacunar dementia and Alzheimer’s disease: a comparison on the neuropsychiatric inventory. Dement Geriatr Cogn Disord 11:294–298
Albus M (2000) Angsterkrankungen. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 61–87
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington
Angst J (1997) Depression and anxiety: implications for nosology, course, and treatment. J Clin Psychiatry 58, Suppl 8:3–5
Ballard C, Neill D, O’Brien J, McKeith IG, Ince P, Perry R (2000) Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59:97–106
Bazire S (2000) Psychotropic drug directory 2000. Mark Allen Publishing, Wilts
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897
Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W (2000) Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 157:89–95
Benoit M, Dygai I, Migneco O, Robert PH, Bertogliati C, Darcourt J, Benoliel J, Aubin-Brunet V, Pringuey D (1999) Behavioral and psychological symptoms in Alzheimer’s disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord 10:511–517
Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792
Brane G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A (1991) Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia. Alzheimer Dis Assoc Disord 3:148–156
Bungener C, Jouvent R, Derouesne C (1996) Affective disturbances in Alzheimer’s disease. J Am Geriatr Soc 44:1066–1071
Caparros-Lefebvre D, Girard-Buttaz I, Reboul S, Lebert F, Cabaret M, Verier A, Steinling M, Pruvo JP, Petit H (1996) Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways. J Neurol 243:248–256
Castillo CS, Schultz SK, Robinson RG (1995) Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry 152:1174–1179
Charney DS, Nagy LM, Bremer JD, Goddard AW, Yehuda R, Southwich SM (1996) Neurobiological mechanisms of human anxiety. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 257–278
Chemerinski E, Petracca G, Manes F, Leiguarda R, Starkstein SE (1998) Prevalence and correlates of anxiety in Alzheimer’s disease. Depress Anxiety 7:166–170
Chen JC, Borson S, Scanlan JM (2000) Stage-specific prevalence of behavioral symptoms in Alzheimer’s disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 8:123–133
Cole SA, Woodard JL, Juncos JL, Kogos JL, Youngstrom EA, Watts RL (1996) Depression and disability in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 8:20–25
Counte MA, Bieliauskas LA, Pavlou M (1983) Stress and personal attitudes in chronic illness. Arch Phys Med Rehabil 64:272–275
Cummings JL (1991) Behavioral complications of drug treatment of Parkinson’s disease. J Am Geriatr Soc 39:708–716
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454
Dennis M, O’Rourke S, Lewis S, Sharpe M, Warlow C (2000) Emotional outcomes after stroke: factors associated with poor outcome. J Neurol Neurosurg Psychiatry 68:47–52
De Rijk C, Bijl RV (1998) De prevalentie van psychische stoornissen bij mensen met de ziekte van Parkinson. Ned Tijdschr Geneeskd 142:27–31
Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 11:51–57
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Ettinger AB, Weisbrot DM, Nolan EE, Gadow KD, Vitale SA, Andriola MR, Lenn NJ, Novak GP, Hermann BP (1998) Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39:595–599
Factor SA, Molho ES, Podskalny GD, Brown D (1995) Parkinson’s disease: drug-induced psychiatric states. Adv Neurol 65:115–138
Fann JR, Katon WJ, Uomoto JM, Esselman PC (1995) Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry 152:1493–1499
Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M (1998) Mood disorders and dysfunction of the hypothalamic-pituitaryadrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55:66–72
Feinstein A, O’Connor P, Gray T, Feinstein K (1999) The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 5:323–326
Fetoni V, Soliveri P, Monza D, Testa D, Girotti F (1999) Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 66:541–544
Fichter MM, Witzke W (1990) Affektive Erkrankungen. In: Fichter MM (Hrsg) Verlauf psychischer Erkrankungen in der Bevölkerung. Springer, Berlin, S 112–144
Fichter MM, Meller I, Schroppel H, Steinkirchner R (1995) Dementia and cognitive impairment in the oldest old in the community. Prevalence and comorbidity. Br J Psychiatry 166:621–629
Fleminger S (1991) Left-sided Parkinson’s disease is associated with greater anxiety and depression. Psycho! Med 21:629–638
Gorman JM, Martinez JM, Liebowitz MR, Fyer AJ, Klein DF (1984) Hypoglycemia and panic attacks. Am J Psychiatry 141:101–102
Gottfries CG, Balldin J, Blennow K, Brane G, Karlsson I, Regland B, Wallin A (1994) Hypothalamic dysfunction in dementia. J Neural Transm Suppl 43:203–209
Häfner H, Veiel H (1986) Epidemiologische Untersuchungen zu Angst and Depression. In: Heimchen H, Linden M (Hrsg) Die Differenzierung von Angst and Depression. Springer, Berlin, S 65–74
Hamilton M (1969) Diagnosis and rating of anxiety. In: Lander MH (ed) Studies on anxiety. Br J Psychiatry Spec Publ 3:76–79 (deutsch: LIPS 4. Aufl. Beltz Test, Weinheim)
Harsch I, Paschke R, Usadel KH (1992) The possible etiological role of psychological disturbances in Graves disease. Acta Med Austriaca 19, Suppl 1:62–65
Helmchen H, Linden M (Hrsg) (1986) Die Differenzierung von Angst and Depression. Springer, Berlin
Henderson R, Kurlan R, Kersun JM, Como P (1992) Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4:257–264
Hodges JR, Warlow CP (1990) Syndromes of transient amnesia: towards classification. A study of 153 cases. J Neurol, Neurosurg, Psychiatry 53:834–843
Irle E, Peper M, Wowra B, Kunze S (1994) Mood changes after surgery for tumors of the cerebral cortex. Arch Neurol 51:164–174
Jorge RE, Robinson RG, Starkstein SE, Arndt SV (1993) Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci 5:369–374
Kathol RG, Delahunt JW (1986) The relationship of anxiety and depression to symptoms of hyperthyroidism using operational criteria. Gen Hosp Psychiatry 8:23–28
Kellner M, Hirschmann M, Wiedemann K (1996) Panic attacks caused by temporal tumors: an exemplary new case and a review. Depress Anxiety 4:243–245
Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. QJM 89:543–551
Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing’s syndrome. Clin Endocrinol (Oxf) 45:715–720
Langdon DW, Thompson AJ (1999) Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 5:94–100
Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G (2000) Medical complications after stroke: a multicenter study. Stroke 31:1223–1229
Lebert F, Pasquier F, Petit H (1994) Behavioral effects of trazodone in Alzheimer’s disease. J Clin Psychiatry 55:536–538
Levy Y, Ziza JM, Nollet D, Landault C, Chapelon C, Bletry O, Zoghbi F, Godeau P (1987) Attaques de panique: un diagnostic a connaitre en medecine interne. Analyse a propos de onze malades et tentative d’explication physiopathologique. Ann Med Interne (Paris) 138:269–274
Lilja A, Salford LG (1997) Early mental changes in patients with astrocytomas with special reference to anxiety and epilepsy. Psychopathology 30:316–323
Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198
Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47:1184–1189
Malt UF, Olafsen OM (1992) Psychological appraisal and emotional response to physical injury: a clinical, phenomenological study of 109 adults. Psychiatr Med 10:117–134
Manchanda R, Schaefer B, McLachlan RS, Blume WT, Wiebe S, Girvin JP, Parrent A, Derry PA (1996) Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry 61:82–89
Mannelli M, Ianni L, Cilotti A, Conti A (1999) Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 141:619–624
Markle RA, Nutt JG, Valentine RJ, Carter JH (1995) Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson’s disease: a double-blind, placebo-controlled study. Neurology 45:1757–1760
Masson F, Maurette P, Salmi LR, Dartigues JF, Vecsey J, Destaillats JM, Erny P (1996) Prevalence of impairments 5 years after a head injury, and their relationship with disabilities and outcome. Brain Inj 10:487–497
Mega MS, Cummings JL, Fiorello T, Gornbein J (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology 46:130–135
Mega MS, Masterman DM, O’Connor SM, Barclay TR, Cummings JL (1999) The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 56:1388–1393
Mendez MF, Martin RJ, Smyth KA, Whitehouse PJ (1990) Psychiatric symptoms associated with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2:28–33
Menza MA, Robertson-Hoffman DE, Bonapace AS (1993) Parkinson’s disease and anxiety: comorbidity with depression. Biol Psychiatry 34:465–470
Menza MA, Cocchiola J, Golbe LI (1995) Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics 36:550–554
Mentzos S (1984) Neurotische Konfliktverarbeitung. Fischer, Frankfurt/M
Musselman DL, Nemeroff CB (1996) Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry Suppl 81:123–128
Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I (1995) A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 36:390–395
Nyth AL, Gottfries CG (1990) The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 157:894–901
Patience DA, Blackwood DH, McColl KE, Moore MR (1994) Patience Porphyr Acute intermittent porphyria and mental illness - a family study. Acta Psychiatr Scand 89:262–267
Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ (1990) Assessment of behavioral and affective symptoms in Alzheimer’s disease. J Geriatr Psychiatry Neurol 3:21–30
Paykel ES (1971) Classification of depressed patients: a cluster analysis derived grouping. Br J Psychiatry 118:275–288
Perini GI, Tosin C, Carraro C, Bernasconi G, Canevini MP, Langer R, Pellegrini A, Testa G (1996) Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J Neurol, Neurosurg, Psychiatry 61:601605
Pflanz S, Besson JA, Ebmeier KP, Simpson S (1991) The clinical manifestation of mental disorder in Huntington’s disease: a retrospective case record study of disease progression. Acta Psychiatr Scand 83:53–60
Prusoff BA, Klerman GL (1974) Differentiating depressed from anxious neurotic outpatients. Arch Gen Psychiatry 30:302–308
Reavley A, Fisher AD, Owen D, Creed FH, Davis JR (1997) Psychological distress in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 47:343–348
Regier DA, Farmer M, Rae DS, Locke BZ, Keith SJ, Judd LL (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiological catchement area (ECA) study. JAMA 264:2511–2518
Richard IH, Schiffer RB, Kurlan R (1996) Anxiety and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 8:383–392
Roth M, Gurney C, Garside RF, Kerr TA (1972) The relationship between anxiety states and depressive illnesses. Part I. Br J Psychiatry 121:147–161
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches and statistisches Manual psychischer Störungen, DSM-IV, 3. Aufl. Hogrefe, Göttingen
Schoenhuber R, Gentilini M (1988) Anxiety and depression after mild head injury: a case control study. J Neurol Neurosurg Psychiatry 51:722–724
Schwartz CE (1999) Teaching coping skills enhances quality of life more than peer support: results of a randomized trial with multiple sclerosis patients. Health Psychol 18:211–220
Schweizer E, Winokur A, Rickels K (1986) Insulin-induced hypoglycemia and panic attacks. Am J Psychiatry 143:654–655
Siemers ER, Shekhar A, Quaid K, Dickson H (1993) Anxiety and motor performance in Parkinson’s disease. Mov Disord 8:501–506
Smith SJ, Young CA (2000) The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 14:50–54
Spielberger CD, Gorsuch RL, Lushene RE (1970) State-trait anxiety inventory. Consulting Psychologists Press, Palo Alto (deutsch: Laux G et al., Hogrefe Testzentrale, Göttingen)
Starkman MN, Zelnik TC, Nesse RM, Cameron OG (1985) Anxiety in patients with pheochromocytomas. Arch Intern Med 145:248–252
Starkman MN, Cameron OG, Nesse RM, Zelnik T (1990) Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med 52:129–142
Starkstein SE, Robinson RG (1992) Neuropsychiatric aspects of cerebral vascular disorders. In: Yudofsky SC, Hales RE (eds) Textbook of Neuropsychiatry. 2“aedn. American Psychiatric Press, Washington, S 449–472
Stavrakaki C, Vargo B (1986) The relationship of anxiety and depression: a review of the literature. Br J Psychiatry 149:7–16
Stein MB, Heuser IJ, Juncos JL, Uhde TW (1990) Anxiety disorders in patients with Parkinson’s disease. Am J Psychiatry 147:217–220
Stenager E, Knudsen L, Jensen K (1994) Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction. Ital J Neurol Sci 15:97–101
Strauss ME, Lee MM, DiFilippo JM (1997) Premorbid personality and behavioral symptoms in Alzheimer disease. Some cautions. Arch Neurol 54:257–259
Strian F (1992) Angstsyndrome. In: Möller AA, Fröscher W (Hrsg) Psychische Störungen bei Epilepsie. Thieme, Stuttgart, S 50–54
Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1993) A comparison of psychiatric symptoms in vascular dementia and Alzheimer’s disease. Am J Psychiatry 150:1806–1812
Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C (1995) Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 52:773–780
Sultzer DL, Mahler ME, Mandelkern MA, Cummings JL, Van Gorp WG, Hinkin CH, Berisford MA (1995) The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 7:476–484
Tattersall RB (1981) Psychiatric aspects of diabetes - a physician’s view. Br J Psychiatry 139:485–493
Teri L, Ferretti LE, Gibbons LE, Logsdon RG, McCurry SM, Kukull WA, McCormick WC, Bowen JD, Larson EB (1999) Anxiety of Alzheimer’s disease: prevalence, and comorbidity. J Gerontol A Biol Sci Med Sci 54:M348–352
Trosch RM, Friedman JH, Lannon MC, Pahwa R, Smith D, Seeberger LC, O’Brien CF, LeWitt PA, Koller WC (1998) Clozapine use in Parkinson’s disease: a retro-spective analysis of a large multicentered clinical experience. Mov Disord 13: 377–382
Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J (1988) A psychiatric and neuropsychological study of patients with untreated Graves’ disease. Gen Hosp Psychiatry 10:49–55
Van Valkenburg C, Akiskal HS, Puzantian V, Rosenthal T (1984) Anxious depressions: Clinical, family history, and naturalistic outcome - comparisons with panic and major depressive disorders. J Affect Dis 6:67–82
Wade DT, Legh-Smith J, Hewer RL (1987) Depressed mood after stroke: a community study of its frequency. Br J Psychiatry 151:200–205
Weiner MF, Svetlik D, Risser RC (1997) What depressive symptoms are reported in Alzheimer’s patients? Int J Geriatr Psychiatry 12(6):648–652.
Wetterling T (2000) Psychopathologische Aspekte zur Diagnostik und Verlaufsmessung von Angststörungen im Alter. In: Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G, Wächtler C (Hrsg) Angst-Sucht-Anpassungsstörungen im Alter. Schriftenreihe der Deutschen Gesellschaft für Gerontopsychiatrie und Psychotherapie, Band 1. Düsseldorf, S 105–109
Wittchen H-U, Essau CA (1993) Comorbidity and mixed anxiety-depressive disorders: is there epidemiologic evidence? J Clin Psychiatry 54, Suppl 1:9–15
Wong MT, Chang PC, Yu YL, Chan YW, Chan V (1994) Psychosocial impact of Huntington’s disease on Hong Kong Chinese families. Acta Psychiatr Scand 90:16–18
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G (1999) Sexual dysfunction in multiple sclerosis: II. Correlation analysis. Mult Scler 5:428–431
Zung WWK (1976) SAS Self-rating Anxiety Scale. In: Guy W (ed) ECDEU Assessment Manual of Psychopharmacology. Rev edn Rockville, Md, S 337–340
Literatur
Aarsland D, Cummings JL, Yenner G, Miller B (1996) Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer’s disease. Am J Psychiatry 153:243–247
Aarsland D, Larsen JP, Cummings JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56:595–601
Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942
Adachi N, Onuma T, Nishiwaki S, Murauchi S, Akanuma N, Ishida S, Takei N (2000) Inter-ictal and post-ictal psychoses in frontal lobe epilepsy: a retrospective comparison with psychoses in temporal lobe epilepsy. Seizure 9:328–335
Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21(2 Suppl):16S–23S
Ala TA, Yang KH, Sung JH, Frey WH (1997) Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer’s disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 62:16–21
Almeida OP, Howard RJ, Levy R, David AS (1995) Psychotic states arising in late life (late paraphrenia) psychopathology and nosology. Br J Psychiatry 166:205–214
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington DC
Arbeitsgemeinschaft für Methodik and Dokumentation in der Psychiatrie (2000) Das AMDP-System. Hogrefe, Göttingen
Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, Agid Y (2000) Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 55:281–288
Ballard CG, Bannister CL, Graham C, Oyebode F, Wilcock G (1995) Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry 167:537–540
Ballard CG, Bannister CL, Patel A, Graham C, Oyebode F, Wilcock G, Chung MC (1995) Classification of psychotic symptoms in dementia sufferers. Acta Psychiatr Scand 92:63–68
Ballard CG, McKeith I, Harrison R, O’Brien J, Thompson P, Lowery K, Perry R, Ince P (1997) A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer’s disease. Int Psychogeriatr 9:381–388
Ballard CG, Holmes C, McKeith I, Neill D, O’Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R (1999) Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry 156:1039–1045
Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG (2000) Delusions and hallucinations in Alzheimer’s disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 15:99–107
Bazire S (2000) Psychotropic drug directory 2000. Mark Allen Publishing, Wilts
Becker D, Hershkowitz M, Maidler N, Rabinowitz M, Floru S (1994) Psychopathology and cognitive decline in dementia. J Nery Ment Dis 182:701–703
Benson DF, Gorman DG (1996) Hallucinations and delusional thinking. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, S 307–323
Bonnet C (1760) Essai analytique sur les facultes de l’ame. Kopenhagen
Bühler KE, Holzbach E (1982) Grundfaktoren und Symptomenkomplexe des Delirium Tremens, Faktor-und gruppenanalytische Untersuchung. Arch Psychiatr Nervenkr 232:451–461
Burke WJ, Roccaforte WH, Wengel SP (1988) Characteristics of elderly patients admitted for the first time to a psychiatric facility. J Geriatr Psychiatry Neurol 1:159–162
Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. II. Disorders of perception. Br J Psychiatry 157:76–81
Chapman FM, Dickinson J, McKeith I, Ballard C (1999) Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer’s disease: treatment implications. Am J Psychiatry 156:1983–1985
Chui HC, Lyness SA, Sobel E, Schneider LS (1994) Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer’s disease. Arch Neurol 51:676–681
Cohen-Mansfield J, Taylor L, Werner P (1998) Delusions and hallucinations in an adult day care population. A longitudinal study. Am J Geriatr Psychiatry 6:104121
Close H, Garety P (1998) Cognitive assessment of voices: further developments in understanding the emotional impact of voices. Br J Clin Psychology 37:173–188
Comella CL, Tanner CM, Ristanavic RK (1993) Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations. Ann Neurol 34:710–714
Conlon P, Trimble MR, Rogers D (1990) A study of epileptic psychosis using magnetic resonance imaging. Br J Psychiatry 156:231–235
Cummings JL, Miller B, Hill MA, Neshkes R (1987) Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 44:389393
Damas-Mora J, Skelton-Robinson M, Jenner FA (1982) The Charles Bonnet syndrome in perspective. Psychol Med 12:251–261
De la Fuente-Fernandez R, Nunez MA, Lopez E (1999) The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson’s disease. Clin Neuropharmacol 22:226–230
Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y (1997) The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 54:257–263
Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 11:51–57
Diederich NJ, Pieri V, Goetz CG (2000) Die optischen Halluzinationen des Parkinson-Patienten und das Charles Bonnet-Syndrom. Eine phänomenologische und pathogenetische Gegenüberstellung. Fortschr Neurol Psychiatr 68:129–136
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Eastwood MR, Corbin S (1983) Hallucinations in patients admitted to a geriatric psychiatry service: review of 42 cases. J Am Geriatr Soc 31:593–597
Eggers C (1975) Die akute optische Halluzinose im Kindesalter. Klinische, differentialtypologische, neurophysiologische and entwicklungspsychologische Aspekte Fortschr Neurol Psychiatr 43:441–470
Fenelon G, Mahieux F, Huon R, Ziegler M (2000) Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 123:733–745
Fernandez A, Lichtshein G, Vieweg WV (1997) The Charles Bonnet syndrome: a review. J Nery Ment Dis 185:195–200
Frieboes RM, Müller U, von Cramon DY (1994) Symptomatische akustische Halluzinose nach traumatischer Hirnschädigung. Literaturübersicht and Fallbericht. Nervenarzt 65:707–711
Friedman JH, Factor SA (2000) Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson’s disease. Mov Disord 15:201–211
Förstl H, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U (1993) Psychotic features and the course of Alzheimer’s disease: relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatr Scand 87:395–399
Gilley DW, Whalen ME, Wilson RS, Bennett DA (1991) Hallucinations and associated factors in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 3:371–376
Gilley DW, Wilson RS, Beckett LA, Evans DA (1997) Psychotic symptoms and physically aggressive behavior in Alzheimer’s disease. J Am Geriatr Soc 45:10741079
Glantz R, Bieliauskas L, Paleologos N (1986) Behavioral indicators of hallucinosis in levodopa-treated Parkinson’s disease. Adv Neurol 45:417–420
Gloor P, Olivier A, Quesney LF, Andermann F, Horowitz S (1982) The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 12:129–144
Goetz CG, Tanner CM, Klawans HL (1982) Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 139:494–497
Goetz CG, Stebbins GT (1995) Mortality and hallucinations in nursing home patients with advanced Parkinson’s disease. Neurology 45:669–671
Goetz CG, Vogel C, Tanner CM, Stebbins GT (1998) Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 51:811–814
Goetz CG, Blasucci LM, Leurgans S, Pappert EJ (2000) Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology 55:789–794
Gold K, Rabins PV (1989) Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Compr Psychiatry 30:90–98
Görgens K, Liedtke M (1998) Charles-Bonnet-Syndrom. Psychiatr Prax 25:85–86
Gormley N, Rizwan MR, Lovestone S (1998) Clinical predictors of aggressive behaviour in Alzheimer’s disease. Int J Geriatr Psychiatry 13:109–115
Gormley N, Rizwan MR (1998) Prevalence and clinical correlates of psychotic symptoms in Alzheimer’s disease. Int J Geriatr Psychiatry 13:410–414
Graham JM, Grunewald RA, Sagar HJ (1997) Hallucinosis in idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 63:434–440
Griffiths TD (2000) Musical hallucinosis in acquired deafness: phenomenology and brain substrate. Brain 123:2065–2076
Hauss K, Reimer F (1970) Visuelle Wahrnehmungsstörungen bei der optischen Halluzinose. Nervenarzt 41:249–251
Hausser-Hauw C, Bancaud J (1987) Gustatory hallucinations in epileptic seizures. Electrophysiological, clinical and anatomical correlates. Brain 110:339–359
Herrmann N, Rivard MF, Flynn M, Ward C, Rabheru K, Campbell B (1998) Risperidone for the treatment of behavioral disturbances in dementia: a case series. J Neuropsychiatry Clin Neurosci 10:220–223
Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H (1998) Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 64:648–652
Holroyd S, Rabins PV, Finkelstein D, Nicholson MC, Chase GA, Wisniewski SC (1992) Visual hallucinations in patients with macular degeneration. Am J Psychiatry 149:1701–1706
Holroyd S, Shepherd ML, Downs JH (2000) Occipital atrophy is associated with visual hallucinations in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 12:25–28
Hori H, Terao T, Shiraishi Y, Nakamura J (2000) Treatment of Charles Bonnet syndrome with valproate. Int Clin Psychopharmacol 15:117–119
Hosty G (1990) Charles Bonnet Syndrom: a description of two cases. Acta Psychiatr Scand 82:316–317
Howard R, Almeida O, Levy R (1994) Phenomenology, demography and diagnosis in late paraphrenia. Psychol Med 24:397–410
Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in meta-chromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neu-rol 49:401–406
Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E (1999) Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 10:1903–1907
Inzelberg R, Kipervasser S, Korczyn AD (1998) Auditory hallucinations in Parkinson’s disease. J Neurol, Neurosurg, Psychiatr 64:533–535
Jibiki I, Maeda T, Kubota T, Yamaguchi N (1993)123I-IMP SPECT brain imaging in epileptic psychosis: a study of two cases of temporal lobe epilepsy with schizophrenia-like syndrome. Neuropsychobiology 28:207–211
Klein C, Kömpf D, Pulkowski U, Moser A, Vieregge P (1997) A study of visual hallucinations in patients with Parkinson’s disease. J Neurol 244:371–377
Kölmel HW (1991) Peduncular hallucinations. J Neurol 238:457–459
Kraft E, Winkelmann J, Trenkwalder C, Auer DP (1999) Visual hallucinations, white matter lesions and disease severity in Parkinson’s disease. Acta Neurol Scand 99:362–367
Kristensen O Sindrup EH (1979) Psychomotor epilepsy and psychosis. III. Social and psychological correlates. Acta Neurol Scand 59:1–9
Lance JW (1976) Simple formed hallucinations confined to the area of a specific visual field defect. Brain 99:719–734
Leopold NA (2000) Risperidone treatment of drug-related psychosis in patients with parkinsonism. Mov Disord 15:301–304
Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, Kopunek S, Baker A (1997) Depression, delusions, and hallucinations in Alzheimer’s disease: no relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 9:64–67
Makoff AJ, Graham JM, Arranz MJ, Forsyth J, Li T, Aitchison KJ, Shaikh S, Grunewald RA (2000) Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson’s disease. Pharmacogenetics 10:43–48
Manford M, Andermann F (1998) Complex visual hallucinations. Clinical and neurobiological insights. Brain 121:1819–1840
McKeith I, Fairbairn A, Perry R, Thompson P, Perry E (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305:673–678
McKeith I, O’Brien J (1999) Dementia with Lewy bodies. Aust N Z J Psychiatry 33:800–808
McShane R, Gedling K, Reading M, McDonald B, Esiri MM, Hope T (1995) Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 59:185–188
Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, Tanimukai S, Kazui H, Hanihara T (2000) Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 57:489–493
Moskovitz C, Moses K, Klawans HL (1978) Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 135:669–675
Naimark D, Jackson E, Rockwell E, Jeste DV (1996) Psychotic symptoms in Parkinson’s disease patients with dementia. J Am Geriatr Soc 44:296–299
Norton-Willson L, Munir M (1987) Visual perceptual disorders resembling the Charles Bonnet syndrome. A study of 434 consecutive patients referred to a psychogeriatric unit. Fam Pract 4:27–35
Okada K, Suyama N, Oguro H, Yamaguchi S, Kobayashi S (1999) Medication-induced hallucination and cerebral blood flow in Parkinson’s disease. J Neurol 246:365–368
Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology 51:351–357
Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S (1999) Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov Disord 14:117–121
Panayiotopoulos CP (1994) Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry 57:1371–1374
Parker G, Roussos J, Mitchell P, Wilhelm K, Austin MP, Hadzi-Pavlovic D (1997) Distinguishing psychotic depression from melancholia. J Affect Disord 42:155167
Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 340:757–763
Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV (2000) Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 54:19651971
Peroutka SJ, Sohmer BH, Kumar AJ, Folstein M, Robinson RG (1982) Hallucinations and delusions following a right temporoparietooccipital infarction. Johns Hopkins Med J 151:181–185
Platz WE, Oberländer FA, Seidel ML (1995) The phenomenology of perceptual hallucinations in alcohol-induced delirium tremens. Psychopathology 28:247–255
Pliskin NH, Kiolbasa TA, Towle VL, Pankow L, Ernest JT, Noronha A, Luchins DJ (1996) Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc 44:1055–1061
Podoll K, Osterheider M, Noth J (1989) Das Charles Bonnet-Syndrom. Fortschr Neurol Psychiatr 57:43–60
Podoll K, Ebel H (1998) Halluzinationen der Körpervergrösserung bei der Migräne. Fortschr Neurol Psychiatr 66:259–270
Rabins PV (1982) Psychopathology of Parkinson’s disease. Compr Psychiatry 23:421–429
Ruggieri S, De Pandis MF, Bonamartini A, Vacca L, Stocchi F (1997) Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson’s disease. Clin Neuropharmacology 20:204–209
Sanchez-Ramos JR, Ortoll R, Paulson GW (1996) Visual hallucinations associated with Parkinson disease. Arch Neurol 53:1265–1268
Sattel H, Geiger-Kabisch C, Schreiter-Gasser U, Besthorn C, Förstl H (1993) Häufigkeit und Bedeutung „nicht-kognitiver“ Symptome bei der Demenz vom Alzheimer-Typ: produktiv psychotische Symptomatik, depressive Störungen und Störungen des Verhaltens. Z Gerontol 26:275–279
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistischer Manual. DSM-IV, 3. Aufl. Hogrefe, Göttingen
Schreier HA (1998) Auditory hallucinations in nonpsychotic children with affective syndromes and migraines: report of 13 cases. J Child Neurol 13:377–382
Sedman G (1967) Experimental and phenomenological approaches to the problem of hallucinations in organic psychosyndromes. Br J Psychiatry 113:1115–1121
Soyka M (1996) Die Alkoholhalluzinose. Klinik, Pathophysiologie und Therapie. Nervenarzt 67:891–895
Soyka M, Zetzsche T, Dresel S, Tatsch K (2000) FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci 12:287–288
Tanner CM, Vogel C, Goetz CG, Klawans HL (1983) Hallucinations in Parkinson’s disease: a population study. Ann Neurol 14:136
Targum SD, Abbott JL (2000) Efficacy of quetiapine in Parkinson’s patients with psychosis. J Clin Psychopharmacol 20:54–60
Teunisse RJ, Cruysberg JR, Verbeek A, Zitman FG (1995) The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 166:254–257
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG (1996) Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 347 (9004):794–797
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Kuin Y, Verbeek AL, Zitman FG (1999) Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet Syndrome. Compr Psychiatry 40:315–319
Trosch RM, Friedman JH, Lannon MC, Pahwa R, Smith D, Seeberger LC, O’Brien CF, LeWitt PA, Koller WC (1998) Clozapine use in Parkinson’s disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord 13: 377–382
Tsuang JW, Irwin MR, Smith TL, Schuckit MA (1994) Characteristics of men with alcoholic hallucinosis. Addiction 89:73–78
Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, McKeith IG (1999) Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 14:459–466
Weiner MF, Risser RC, Cullum CM, Honig L, White C 3rdSpeciale S, Rosenberg RN (1996) Alzheimer’s disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 153:1269–1273
Weingarten SM, Cherlow DG, Holmgren E (1977) The relationship of hallucinations to the depth structures of the temporal lobe. Acta Neurochir 237 (Suppl 24):199–216
Wetterling T (1994) Delir - Stand der Forschung. Fortschr Neurol Psychiat 62: 280–289
Wetterling T, Junghanns K (2001) Auswertung der Basisdokumentationsdaten der Lübecker psychiatrischen Universitätsklinik 1990–1998 (MUL). Unveröffentlicht
Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA (2000) Hallucinations, delusions, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:172–177
Winawer MR, Ottman R, Hauser WA, Pedley TA (2000) Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 54:2173–2176
Workman RH Jr, Orengo CA, Bakey AA, Molinari VA, Kunik ME (1997) The use of risperidone for psychosis and agitation in demented patients with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 9:594–597
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 146:577–587
Literatur
Aarsland D, Cummings JL, Yenner G, Miller B (1996) Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer’s disease. Am J Psychiatry 153:243–247
Aarsland D, Larsen JP, Cummings JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56:595–601
Ahlsen V (1968) Schizophreniforme Psychosen mit belangvollem körperlichem Befund. Fortschr Neurol Psychiat 37:448–457
Ahlsen V, Gremse B, Kröber HL (1982) Symptomatische Schizophrenien und Zyklothymien - phänomenologische Überschneidung organischer und endogener Psychosyndrome? In: Huber G (Hrsg) Endogene Psychosen: Diagnose, Basissymptome und biologische Parameter. Schattauer, Stuttgart, S 27–36
Albert E (1987) On organically based hallucinatory-delusional psychoses. Psychopathology 20:144–154
Albert ML (1973) A simple test of visual neglect. Neurology 23:658–664
Almeida OP, Howard RI, Levy R, David AS (1995) Psychotic states arising in late life (late paraphrenia) psychopathology and nosology. Br J Psychiatry 166:205–214
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington DC, S 165–174
Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie (2000) Das AMDP-System. Hogrefe, Göttingen
Baker FM, Kokmen E, Chandra V, Schoenberg BS (1991) Psychiatric symptoms in cases of clinically diagnosed Alzheimer’s disease. J Geriatr Psychiatry Neurol 4:71–78
Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G (1995) Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry 167:537–540
Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG (2000) Delusions and hallucinations in Alzheimer’s disease: prevalence and clinical correlates. Int J Geriatr Psychiatry 15:99–107
Bazire S (2000) Psychotropic drug directory 2000. Mark Allen Publishing, Wilts
Becker H (1997) Psychotische Erscheinungsbilder als Erstmanifestation einer multiplen Sklerose? (MS). Psychiatr Prax 24:69–72
Benson DF, Gorman DG (1996) Hallucinations and delusional thinking. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, S 307–323
Binetti G, Bianchetti A, Padovani A, Lenzi G, De Leo D, Trabucchi M (1993) Delusions in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 88:5–9
Birkmayer W (1978) Toxic delirium after L-Dopa medication. J Neural Transm, Suppl 14:163–166
Boston Collaborative Drug Surveillance Program (1972) Acute reverse reaction to prednisone in relation to dosage. Clin Pharmacol Ther 13:694–697
Brainin M, Presslich O, Eichberger G, Friedmann A, Marksteiner A, Maida E (1982) Akute virale Enzephalitis mit primär psychotischer Symptomatik - Diagnose, Verlauf and Prognose. Fortschr Neurol Psychiatr 50:387–395
Brownlie BE, Rae AM, Walshe JW, Wells JE (2000) Psychoses associated with thyrotoxicosis - “thyrotoxic psychosis”. A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 142:438–444
Bruton CJ, Stevens JR, Frith CD (1994) Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology 44:34–42
Burns A, Jacoby R, Levy R (1990) Psychiatric phenomena in Alzheimer’s disease. I. Disorders of thought content. Br J Psychiatry 157:72–76
Caligiuri MP, Peavy G (2000) An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 12:34–39
Christenson R, Blazer D (1984) Epidemiology of persecutory ideation in an elderly population in the community. Am J Psychiatry 141:1088–1091
Cohen-Mansfield J, Taylor L, Werner P (1998) Delusions and hallucinations in an adult day care population. A longitudinal study. Am J Geriatr Psychiatry 6:104121
Cooper B, Curry AF (1976) The pathology of deafness in the paranoid and affective psychosis of later life. J Psychosom Res 20:97–105
Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ (1993) Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc 41:31–37
Cummings JL (1985) Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry 146:184–197
Cummings JL, Miller B, Hill MA, Neshkes R (1987) Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 44:389393
Cummings JL, Gorman DG, Shapira J (1993) Physostigmine ameliorates the delusions of Alzheimer’s disease. Biol Psychiatry 33:536–541
Cutting J (1987) The phenomenology of acute organic psychosis: comparison with acute schizophrenia. Br J Psychiatry 151:324–332
Danielczyk W (1979) Akute pharmakotoxische Psychosen bei chronischen zerebralen Erkrankungen. Wien Med Wochenschr 129, Suppl 55:1–15
Davison K, Bagley CR (1969) Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. Br J Psychiatry Spec Issue No 4:113–183
De Deyn PP, Rabheru K, Rasmussen A, Bocksberger JP, Dautzenberg PL, Eriksson S, Lawlor BA (1999) A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53:946–955
Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF (1991) Psychosis and physical aggression in probable Alzheimer’s disease. Am J Psychiatry 148:11591163
Devanand DP, Sackeim HA, Brown RP, Mayeux R (1989) A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer’s disease. Arch Neurol 46:854–857
Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R, Stern Y (1992) The Columbia University Scale for Psychopathology in Alzheimer’s disease. Arch Neurol 49:371–376
Devanand DP, Marder K, Michaels KS, Sackeim HA, Bell K, Sullivan MA, Cooper TB, Pelton GH, Mayeux R (1998) A randomized, placebo-controlled dose-compari-son trial of haloperidol for psychosis and disruptive behaviors in Alzheimer’s disease. Am J Psychiatry 155:1512–1520
Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y (1997) The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 54:257–263
Devinsky O, Abramson H, Alper K, FitzGerald LS, Perrine K, Calderon J, Luciano D (1995) Postictal psychosis: a case control series of 20 patients and 150 controls. Epilepsy Res 20:247–253
Dewhurst K, Oliver J, Trick K, McKnight AL (1969) Neuropsychiatric aspects of Huntington’s disease. Confinia Neurologica 31:258–268
Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C (1999) Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 11:51–57
Diehl LW (1992) Epidemiologie psychischer Störungen. In: Möller AA, Fröscher W (Hrsg) Psychische Störungen bei Epilepsie. Thieme, Stuttgart, S 6–10
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Drevets WC, Rubin EH (1989) Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 25:39–48
Eastwood MR, Corbin S (1983) Hallucinations in patients admitted to a geriatric psychiatry service: review of 42 cases. J Am Geriatr Soc 31:593–597
Engler F, Vetter P (1991) Affektive und schizophrene Syndrome bei Multipler Sklerose. Literaturübersicht und Kasuistiken. Schweiz Arch Neurol Psychiatr 142: 367–378
Factor SA, Molho ES, Podskalny GD, Brown D (1995) Parkinson’s disease: drug-induced psychiatric states. Adv Neurol 65:115–138
Falkai P (1996) Differential diagnosis in acute psychotic episode. Int Clin Psychopharmacol 11 Suppl 2:13–17
Falkai P, Vogeley K, Bogerts B (2000) Schizophrenie. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 23–34
Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151:1571–1583
Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680–685
Felgenhauer K (1990) Psychiatric disorders in the encephalitic form of multiple sclerosis. J Neurol 237:11–18
Förstl H, Burns A, Jacoby R, Levy R (1991) Neuroanatomical correlates of clinical misidentification and misperception in senile dementia of the Alzheimer type. J Clin Psychiatry 52:268–271
Förstl H, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U (1993) Psychotic features and the course of Alzheimer’s disease: relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatr Scand 87:395–399
Förstl H, Besthorn C, Burns A, Geiger-Kabisch C, Levy R, Sattel A (1994) Delusional misidentification in Alzheimer’s disease: a summary of clinical and biological aspects. Psychopathology 27:194–199
Förstl H, Dalgalarrondo P, Riecher-Rössler A, Lotz M, Geiger-Kabisch C, Hentschel F (1994) Organic factors and the clinical features of late paranoid psy-chosis: a comparison with Alzheimer’s disease and normal ageing. Acta Psychiatr Scand 89:335–840
Friedberg G, Zoldan J, Weizman A, Melamed E (1998) Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson’s disease. Clin Neuropharmacol 21:280–284
Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL (1999) Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 10:130–138
Fuchs T (1993) Wahnsyndrome bei sensorischer Beeinträchtigung - Überblick and Modellvorstellung. Fortschr Neurol Psychiat 61:257–266
Galasko D, Kwo-On-Yuen PF, Thal L (1988) Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am 11:151–166
Geroldi C, Akkawi NM, Galluzzi S, Ubezio M, Binetti G, Zanetti O, Trabucchi M, Frisoni GB (2000) Temporal lobe asymmetry in patients with Alzheimer’s disease with delusions. J Neurol Neurosurg Psychiatry 69:187–191
Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, Simon ES, Korczyn AD (2000) Risk factors for dementia, depression and psychosis in longstanding Parkinson’s disease. J Neural Transm 107:59–71
Gilley DW, Wilson RS, Beckett LA, Evans DA (1997) Psychotic symptoms and physically aggressive behavior in Alzheimer’s disease. J Am Geriatr Soc 45:10741079
Gormley N, Rizwan MR, Lovestone S (1998) Clinical predictors of aggressive behaviour in Alzheimer’s disease. Int J Geriatr Psychiatry 13:109–115
Gormley N, Rizwan MR (1998) Prevalence and clinical correlates of psychotic symptoms in Alzheimer’s disease. Int J Geriatr Psychiatry 13:410–414
Günther W, Baghai T, Naber D, Spatz R, Hippius H (1993) EEG alterations and seizures during treatment with clozapine. A retrospective study of 283 patients. Pharmacopsychiatry 26:69–74
Gutzmann H, Kühl K-H, Göhringer K (Hrsg) (2000) Das AGP-System, 2. Aufl. Hogrefe, Göttingen
Haji MIHI, Loh WF, Sofiah A (1999) Childhood cerebral lupus in an Oriental population. Brain Dev 21:229–235
Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593–624
Harwood DG, Barker WW, Ownby RL, Duara R (1999) Prevalence and correlates of Capgras syndrome in Alzheimer’s disease. Int J Geriatr Psychiatry 14:415–420
Herrmann N, Rivard MF, Flynn M, Ward C, Rabheru K, Campbell B (1998) Risperidone for the treatment of behavioral disturbances in dementia: a case series. J Neuropsychiatry Clin Neurosci 10:220–223
Hewer W, Junker D, Dressing H, Olbrich R (1994) Psychosen bei Enzephalitiden unklarer Ätiologie. Atypische Verlaufsformen einer Multiplen Sklerose? Nervenarzt 65:163–168
Hirono N, Mori E, Ishii K, Kitagaki H, Sasaki M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Yamashita H (1998) Alteration of regional cerebral glucose utilization with delusions in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 10:433–439
Hirono N, Mori E, Yasuda M, Ikejiri Y, Imamura T, Shimomura T, Ikeda M, Hashimoto M, Yamashita H (1998) Factors associated with psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 64:648–652
Honer WG, Hurwitz T, Li DK, Palmer M, Paty DW (1987) Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 44:187–190
Hwang JP, Yang CH, Tsai SJ, Liu KM (1997) Delusions of theft in dementia of the Alzheimer type: a preliminary report. Alzheimer Dis Assoc Disord 11:110–112
Hwang JP, Tsai SJ, Yang CH, Liu KM, Lirng JF (1999) Persecutory delusions in dementia. J Clin Psychiatry 60:550–553
Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in meta-chromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neu-rol 49:401–406
Janzarik W (1973) Über das Kontaktmangelparanoid des höheren Alters and den Syndromcharakter des schizophrenen Krankseins. Nervenarzt 44:515–526
Jaspers K (1913) Allgemeine Psychopathologie. Springer, Berlin
Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ (1992) Cognitive deficits of patients with Alzheimer’s disease with and without delusions. Am J Psychiatry 149:184–189
Jeste DV, Galasko D, Corey-Bloom J, Walens S, Granholm E (1996) Neuropsychiatric aspects of the schizophrenias. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, S 325–344
Jibiki I, Maeda T, Kubota T, Yamaguchi N (1993)123I-IMP SPECT brain imaging in epileptic psychosis: a study of two cases of temporal lobe epilepsy with schizophrenia-like syndrome. Neuropsychobiology 28:207–211
Johnstone EC, Macmillan JF, Crow TJ (1987) The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med 17:371–379
Jovic N (1988) Das paranoide Syndrom während des Alterns. In: Uchtenhagen A, Jovic N (Hrsg) Psychogeriatrie. Ansanger, Heidelberg, S 113–128
Kandel ER (2000) Disorders of thought and volition: schizophrenia. In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of neural science4thedn. McGraw-Hill, New York, S 1188–1208
Kanemoto K, Kawasaki J, Kawai I (1996) Postictal psychosis: a comparison with acute interictal and chronic psychoses. Epilepsia 37:551–556
Karnath H-O (2000) Neglect. In: Hartje W, Poeck K (eds) Klinische Neuropsychologie, 4. Aufl. Thieme, Stuttgart, S 260–277
Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 60:107–115
Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R (1995) SPECT findings on psychosis in Alzheimer’s disease. Am J Psychiatry 152:1470–1475
Kraepelin E (1915) Der Verfolgungswahn der Schwerhörigen. In: Kraepelin E: Psychiatrie, 8. Aufl. Barth, Leipzig, S 1441–1448
Kudrjavcev T (1978) Neurologic complications of thyroid dysfunction. Adv Neurol 19:619–636
Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A (1996) Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer’s disease. Am J Psychiatry 153:1438–1443
Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF (1991) Alzheimer’s disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 41:906–912
Lopez OL, Wisniewski S, Hamilton RL, Becker JT, Kaufer DI, DeKosky ST (2000) Predictors of progression in patients with AD and Lewy bodies. Neurology 54:1774–1779
Magni E, Binetti G, Bianchetti A, Trabucchi M (1996) Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol 9:123–126
Marneros A (1988) Schizophrenic first-rank symptoms in organic mental disorders. Br J Psychiatry 152:625–628
Marneros A, Deister A, Rohde A (1988) Delusional parasitosis. A comparative study to late-onset schizophrenia and organic mental disorders due to cerebral arteriosclerosis. Psychopathology 21:267–274
Marshall EJ, Syed GM, Fenwick PB, Lishman WA (1993) A pilot study of schizophrenia-like psychosis in epilepsy using single-photon emission computerised tomography. Br J Psychiatry 163:32–36
McKeith I, Fairbairn A, Perry R, Thompson P, Perry E (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 305:673–678
Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:167–171
Mendez MF, Grau R, Doss RC, Taylor JL (1993) Schizophrenia in epilepsy: seizure and psychosis variables. Neurology 43:1073–1077
Mentis MJ, Weinstein EA, Horwitz B, McIntosh AR, Pietrini P, Alexander GE, Furey M, Murphy DG (1995) Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biol Psychiatry 38:438–449
Migliorelli R, Petracca G, Teson A, Sabe L, Leiguarda R, Starkstein SE (1995) Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease. Psychol Med 25:505–513
Naimark D, Jackson E, Rockwell E, leste DV (1996) Psychotic symptoms in Parkinson’s disease patients with dementia. J Am Geriatr Soc 44:296–299
Nasrallah HA (1992) The neuropsychiatry of schizophrenia. In: Yudofsky SC, Hales RE (eds) Textbook of neuropsychiatry, 2’1edn. American Psychiatric Press, Washington, S 621–638
Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 340:757–763
Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV (2000) Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 54:19651971
Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50:743–755
Pertouka SJ, Sohmer BH, Kumer AJ, Folstein M, Robinson RG (1982) Hallucinations and delusions following a right temporoparieto-occipital infarction. J Hopkins Med 1 151:181–185
Poeck K (2000) Anosognosie and halbseitige Vernachlässigung. In: Hartje W, Poeck K (Hrsg) Klinische Neuropsychologie, 4. Aufl. Thieme, Stuttgart, S 278–282
Portwich P, Barocka A (1998) Das Capgras-Syndrom and andere Syndrome wahnhafter Verkennung (DMS). Nervenheilkunde 17:296–300
Rabins P, Pearlson G, Jayaram G, Steele C, Tune L (1987) Increased ventricle-tobrain ratio in late-onset schizophrenia. Am J Psychiatry 144:1216–1218
Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A (1987) Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry 48, Suppl 7:9–15
Roane DM, Rogers JD, Robinson JH, Feinberg TE (1998) Delusional misidentification in association with parkinsonism. J Neuropsychiatry Clin Neurosci 10:194–198
Roelcke U, Barnett W, Wilder-Smith E, Sigmund D, Hacke W (1992) Untreated neuroborreliosis: Bannwarth’s syndrome evolving into acute schizophrenia-like psychosis. A case report. J Neurol 239:129–131
Rondot P, de Recondo J, Coignet A, Ziegler M (1984) Mental disorders in Parkinson’s disease after treatment with L-DOPA. Adv Neurol 40:1020–1023
Rosen J, Zubenko GS (1991) Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer’s disease. Biol Psychiatry 29:224–232
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual. DSM-IV, 3. Aufl. Hogrefe, Göttingen
Sattel H, Geiger-Kabisch C, Schreiter-Gasser U, Besthorn C, Förstl H (1993) Häufigkeit und Bedeutung „nicht-kognitiver“ Symptome bei der Demenz vom Alzheimer-Typ: produktiv psychotische Symptomatik, depressive Störungen und Störungen des Verhaltens. Z Gerontol 26:275–279
Scharfetter C (1997) Wahn. In: Scharfetter C: Allgemeine Psychopathologie. Thieme, Stuttgart, S 216–265
Schifferdecker M, Krahl A, Krekel NO (1995) Psychosen bei multipler Sklerose - eine Neubewertung. Fortschr Neurol Psychiatr 63:310–319
Schmidt D, Fröscher W, Krämer G (1992) Medikamentöse Standardtherapie der Epilepsien des Jugendlichen-und Erwachsenenalters. Nervenheilkunde 11:418426
Schneider E, Fischer P-A, Jacobi P, Grotz A (1984) Exogene Psychosen beim Parkinsonsyndrom. Häufigkeit und Entstehungsbedingungen. Fortschr Neurol Psychiat 52:207–214
Schneider K (1973) Klinische Psychopathologie, 13. Aufl. Thieme, Stuttgart
Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB (1992) The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 19:47–52
Soyka M, Saß H, Völcker A (1989) Der alkoholische Eifersuchtswahn - Psychopathologische Charakteristika zweier Verlaufstypen. Psychiat Prax 16:189–193
Soyka M, Naber G, Völcker A (1991) Prevalence of delusional jealousy in different psychiatric disorders. Br J Psychiatry 158:549–553
Staff RT, Venneri A, Gemmell HG, Shanks MF, Pestell SJ, Murray AD (2000) HMPAO SPECT imaging of Alzheimer’s disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping. J Nucl Med 41:1451–1455
Starkstein SE, Vazquez S, Petracca G, Sabe L, Migliorelli R, Teson A, Leiguarda R (1994) A SPECT study of delusions in Alzheimer’s disease. Neurology 44:20552059
Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer’s disease: prospective analyses from the Predictors Study. Neurology 44:2300–2307
Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A (2000) Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 57:968–976
Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1992) Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 40:549–555
Sweet RA, Nimgaonkar VL, Kamboh MI, Lopez OL, Zhang F, DeKosky ST (1998) Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch Neurol 55:1335–1340
Täschner K-L (1992) Drogeninduzierte Psychose“ oder „Psychose and Drogen-abusus”. In: Schwoon DR, Krausz M (Hrsg) Psychose and Sucht. Krankheitsmodelle, Verbreitung, therapeutische Ansätze. Lambertus, Freiburg, S 35–40
Tennant FS, Groesbeck CJ (1972) Psychiatric effects of Hashish. Arch Gen Psychiatry 27:133–136
Thornicroft G (1990) Cannabis and Psychosis. Br J Psychiatry 157:25–33
Trabert W (1991) Zur Epidemiologie des Dermatozoenwahns. Nervenarzt 62:165–169
Tsai SJ, Hwang JP, Yang CH, Liu KM (1997) Delusional jealousy in dementia. J Clin Psychiatry 58:492–494
Ulmar G, Menges-Fleig (1998) Das Capgras-Syndrom and andere wahnhafte Doppelgängerphänomene. Nervenheilkunde 17:224–228
Umbricht D, Degreef G, Barr WB, Lieberman JA, Pollack S, Schaul N (1995) Postictal and chronic psychoses in patients with temporal lobe epilepsy. Am J Psychiatry 152:224–231
Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, McKeith IG (1999) Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 14:459–466
Weiner MF, Risser RC, Cullum CM, Honig L, White C , Speciale S, Rosenberg RN (1996) Alzheimer’s disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 153:1269–1273
Wetterling T (1994) Differentialdiagnose dementieller Abbauprozesse. Thieme, Stuttgart
Wetterling T, Kanitz R-D (1993) Schizophreniforme Psychose bei Patienten mit suprasellärem Hypophysenadenom. Psycho 19:261–266
Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA (2000) Hallucinations, delusions, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:172–177
Wolters EC, Jansen EN, Tuynman-Qua HG, Bergmans PL (1996) Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 47:1085–1087
Workman RH Jr, Orengo CA, Bakey AA, Molinari VA, Kunik ME (1997) The use of risperidone for psychosis and agitation in demented patients with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 9:594–597
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Wragg RE, Jeste DV (1989) Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 146:577–587
Zubenko GS, Moossy J, Martinez AJ, Rao G, Claassen D, Rosen J, Kopp U (1991) Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 48:619–624
Literatur
Agronin ME (1998) Personality and psychopathology in late life. Geriatrics 53 Suppl 1:35–40
Aitken L, Simpson S, Burns A (1999) Personality change in dementia. Int Psychogeriatr 11:263–271
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. Third edition (DSM-III). American Psychiatric Association, Washington DC
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Association, Washington DC
Balestrieri M, Nacmias B, Sorbi S, Marcon G (2000) Are premorbid personality traits linked to the risk of Alzheimer’s Disease? A case series of subjects with familial mutation. Psychother Psychosom 69:335–338
Boerner RJ, Kapfhammer HP (1999) Psychopathological changes and cognitive impairment in encephalomyelitis disseminata. Eur Arch Psychiatry Clin Neurosci 249:96–102
Blumer D (1995) Personality disorders in epilepsy. In: Ratey JJ (ed) Neuropsychiatry and personality disorders. Blackwell Science, Oxford, S 230–263
Blumer D (1999) Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology 53 (5 Suppl 2):9–12
Bronisch T (2000) Persönlichkeitsstörung. In: Förstl H (Hrsg) Klinische NeuroPsychiatrie. Thieme, Stuttgart, S 116–135
Brooks N (1988) Personality change after severe head injury. Acta Neurochir Suppl 44:59–64
Burke JM, Smith SA, Imhoff CL (1989) The response styles of post-acute traumatic brain-injured patients on the MMPI. Brain Inj 3:35–40
Butcher JN, Dahlstrom WG, Graham JR, Tellegen AM, Kaemmer B (1989) MMPI2: Manual for administration and scoring. University of Minnesota Press, Minneapolis
Cloninger CR (1987) A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44:573–588
Cummings JL (1993) Frontal-subcortical circuits and human behavior. Arch Neu-rol 50:873–880
Dawson DV, Welsh-Bohmer KA, Siegler IC (2000) Premorbid personality predicts level of rated personality change in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 14:11–19
Devinsky O, Najjar S (1999) Evidence against the existence of a temporal lobe epilepsy personality syndrome. Neurology 53 (5 Suppl 2):13–25
Diederich N, Karenberg A, Peters UH (1988) Psychopathologische Bilder bei der HIV-Infektion: AIDS-Lethargie und AIDS-Demenz. Fortschr Neurol Psychiatr 56: 173–185
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Eames P (1997) Traumatic brain injury. Curr Opin Psychiatry 10:49–52
Formisano R, Schmidhuber-Eiler B, Saltuari L, Cigany E, Birbamer G, Gerstenbrand F (1991) Neuropsychological outcome after traumatic temporal lobe damage. Acta Neurochir 109:1–4
Franulic A, Horta E, Maturana R, Scherpenisse J, Carbonell C (2000) Organic personality disorder after traumatic brain injury: cognitive, anatomic and psychosocial factors. A 6 month follow-up. Brain Inj 14:431–439
Freyberger HJ, Schmidt LG (1999) Organische Wesensänderung. In: Psychiatrie der Gegenwart. In: Helmchen H, Henn F, Lauter H, Sartorius N (Hrsg) Psychische Störungen bei somatischen Krankheiten. Psychiatrie der Gegenwart, 4. Aufl. Springer, Berlin, S 271–286
Fuster JM (1996) Frontal lobe lesions. In: Fogel BS, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 407–413
Grant DA, Berg BA (1994) Wisconsin card sorting test (WCST). 2. Aufl. Hogrefe Testzentrale. Göttingen
Herpertz S, Saß H (1997) Psychopathy and antisocial syndromes. Curr Opin Psychiatry 10:436–440
Hibbard MR, Bogdany J, Uysal S, Kepler K, Silver JM, Gordon WA, Haddad L (2000) Axis II psychopathology in individuals with traumatic brain injury. Brain Inj 14:45–61
Huber G (1972) Klinik und Psychopathologie der organischen Psychosen. In: Kisker KP, Meyer JE, Müller M, Strömgren E (Hrsg) Psychiatrie der Gegenwart. Forschung und Praxis, Band II. Springer, Berlin, S 71–147
Hunger J (1992) Persönlichkeitsstörung bei Epilepsie. In: Möller AA, Fröscher W (Hrsg) Psychische Störungen bei Epilepsie. Thieme, Stuttgart, S 58–63
Jackson HJ, Burgess PM (2000) Personality disorders in the community: a report from the Australian National Survey of Mental Health and Wellbeing. Soc Psychiatry Psychiatr Epidemiol 35:531–538
Kant R, Duffy JD, Pivovarnik (1998) Prevalence of apathy following head injury. Brain Inj 12:87–92
Kertesz A, Nadkarni N, Davidson W, Thomas AW (2000) The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol 6:460–468
Kinzel W (1972) Das irreversible psychische Defektsyndrom nach Hirntrauma. Eine Übersicht über die literarische Produktion zu einem vielschichtigen Problem. Fortschr Neurol Psychiatr Grenzgeb 40:169–219
Kraeplin E (1904) Das epileptische Irresein. In: Kraeplin E: Psychiatrie. Ein Lehrbuch für Studierende und Ärzte: Band II, 7. Aufl. Barth, Leipzig, S 623–687
Kurz A (1994) Historische Entwicklung und Abgrenzung des Begriffs der Wesensänderung. In: Suchenwirth RMA, Ritter G (Hrsg) Begutachtung der hirnorganischen Wesensänderung. Fischer, Stuttgart, S 5–14
Levin DN, Grossman RG (1978) Behavioral sequelae of closed head injury: a quantitative approach. Arch Neurol 35:720–727
Levin DN, Grossman RG, Rose JE, Teasdale G (1979) Long-term neuropsychological outcome of closed head injury. J Neurol Neurosurg Psychiatry 50:412–422
Lopez-Rodriguez F, Altshuler L, Kay J, Delarhim S, Mendez M, Engel J (1999) Personality disorders among medically refractory epileptic patients. J Neuropsychiatry Clin Neurosci 11:464–469
Manchanda R, Schaefer B, McLachlan RS, Blume WT, Wiebe S, Girvin JP, Parrent A, Derry PA (1996) Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry 61:82–89
Max JE, Castillo CS, Lindgren SD, Arndt S (1998) The Neuropsychiatric Rating Schedule: reliability and validity. J Am Acad Child Adolesc Psychiatry 37:297–304
Max JE, Koele SL, Castillo CC, Lindgren SD, Arndt S, Bokura H, Robin DA, Smith WL, Sato Y (2000) Personality change disorder in children and adolescents following traumatic brain injury. J Int Neuropsychol Soc 6:279–289
Meins W, Dammast J (2000) Do personality traits predict the occurrence of Alzheimer’s disease? Int J Geriatr Psychiatry 15:120–124
Mendez MF (1994) Neuropsychiatric aspects of epilepsy. In: Coffey CE, Cummings JL (eds) Textbook of geriatric neuropsychiatry. American Psychiatric Press, Washington, S 510–521
Mendez MF, Doss RC, Taylor JL, Arguello R (1995) Relationship of seizure variables to personality disorders in epilepsy. J Neuropsychiatry Clin Neurosci 5:283286
Motomura U, Sawada T, Inoue N, Asaba H, Sakai T (1988) Neuropsychological and neuropsychiatric findings in right hemisphere damaged patients. Jpn J Psychiatry Neurol 42:747–752
Müller P (1994) Wesensänderung - sonstige Formen und Kombinationen. In: Suchenwirth RMA, Ritter G (Hrsg) Begutachtung der hirnorganischen Wesensänderung. Fischer, Stuttgart, S 107–116
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554
Oddy M, Humphrey M, Uttley D (1978) Subjective impairment and social recovery after closed head injury. J Neurol Neurosurg Psychiatry 41:611–616
Oddy M, Caughlan T, Tyerman A, Jenkins T (1985) Social adjustment after closed head injury: a further follow-up seven years after injury. J Neurol Neurosurg Psychiatry 48:564–586
Quatember R (1994) Bedeutung klinisch-psychologischer Untersuchungsergebnisse für die Begutachtung der hirnorganischen Wesensänderung. In: Suchenwirth RMA, Ritter G (Hrsg) Begutachtung der hirnorganischen Wesensänderung. Fischer, Stuttgart, S 42–47
Paulsen JS, Ready RE, Stout JC, Salmon DP, Thal LJ, Grant I, Jeste DV (2000) Neurobehaviors and psychotic symptoms in Alzheimer’s disease. J Int Neuropsychol Soc 6:815–820
Perini GI, Tosin C, Carraro C, Bernasconi G, Canevini MP, Canger R, Pellegrini A, Testa G (1996) Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 61:601–605
Perkins DO, Davidson EJ, Leserman J, Liao D, Evans DL (1993) Personality disorder in patients infected with HIV. A controlled study with implications for clinical care. Am J Psychiatry 150:309–315
Pohlmann-Eden B (2000) Epilepsie. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 270–297
Samuels JF, Nestadt G, Romanoski AJ, Folstein MF, McHugh PR (1994) DSM-III personality disorders in the community. Am J Psychiatry 151:1055–1062
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual. DSM-IV, 3. Aufl. Hogrefe, Göttingen
Scherzer E, Wurzer W (1994) Wesensänderung nach Hirntrauma. In: Suchenwirth RMA, Ritter G (Hrsg) Begutachtung der hirnorganischen Wesensänderung. Fischer, Stuttgart, S 48–61
Strauss ME, Lee MM, DiFilippo JM (1997) Premorbid personality and behavioral symptoms in Alzheimer disease. Some cautions. Arch Neurol 54:257–259
Suchenwirth RMA (1994) Zur Psychopathologie der hirnorganischen Wesensänderung. In: Suchenwirth RMA, Ritter G (Hrsg) Begutachtung der hirnorganischen Wesensänderung. Fischer, Stuttgart, S 15–31
Supprian T, Müller U, Hofmann E, Becker T (1996) Psychiatrische Folgeerkrankungen nach Schädel-Hirn-Trauma - eine Literaturübersicht. Psychiatr Prax 23: 161–167
Swanson SJ, Rao SM, Grafman J, Salazar AM, Kraft J (1995) The relationship between seizure subtype and interictal personality. Results from the Vietnam Head Injury Study. Brain 118:91–103
Teri L (1997) Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver distress. Alzheimer Dis Assoc Disord 11 Suppl 4:35–38
Trimble MR (1988) Psychiatrische und psychologische Aspekte der Epilepsie. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart 6. Organische Psychosen. Springer, Berlin, S 325–363
Trimble MR, Ring HA, Schmitz B (1996) Neuropsychiatric aspects of epilepsy. In: Fogel SB, Schiffer RB, Rao SM (eds) Neuropsychiatry. Williams & Wilkins, Baltimore, S 771–803
Van Reekum R, Conway CA, Gansler D, White R, Bachman DL (1993) Neurobehavioral study of borderline personality disorder. J Psychiatry Neurosci 18:121–129
Van Reekum R, Bolago I, Finlayson MA, Garner S, Links PS (1996) Psychiatric disorders after traumatic brain injury. Brain Inj 10:319–327
Varney NR, Roberts RJ, Springer JA, Connell SK, Wood PS (1997) Neuropsychiatric sequelae of cerebral malaria in Vietnam veterans. J Nerv Ment Dis 185:695703
Vieregge P (2000) Hirntumoren. In: Förstl H (Hrsg) Klinische Neuro-Psychiatrie. Thieme, Stuttgart, S 298–310
Weddell R, Oddy M, Jenkins D (1980) Social adjustment after rehabilitation: a two year follow-up of patients with severe head injury. Psychol Med 10:257–263
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Literatur
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Fourth edition (DSM-IV). American Psychiatric Press, Washington DC, S 165–174
Boerner RJ (1996) Organische katatone Störung - Über das Auftreten eines katatonen Syndroms bei einer Patientin mit Encephalomyelitis disseminata. Psychiatr Prax 23:40
Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB (1997) Progression to dementia in patients with isolated memory loss. Lancet 349:763–765
Bräunig P, Krüger S, Höffler J, Shugar G, Börner I (1999) Entwicklung, Anwendung und Reliabilität einer Katatonie-Skala. In: Bräunig P (Hrsg) Motorische Störungen bei schizophrenen Psychosen. Schattauer, Stuttgart, S 41–67
Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 122:1341–1348
Carroll BT, Anfinson TJ, Kennedy JC, Yendrek R, Boutros M, Bilon A (1994) Catatonic disorder due to general medical conditions. J Neuropsychiatry Clin Neurosci 6:122–133
Christensen H, O’Brien J (2000) Age-related cognitive decline and its relationship to dementia. In: O’Brien J, Ames D, Burns A (eds) Dementia, 2ndedn. Arnold, London, S 16–27
Dilling H, Mombour W, Schmidt MH (1994) Internationale Klassifikation psychischer Störungen. Forschungskriterien. Huber, Bern
Dilling H, Mombour W, Schmidt MH (2000) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien, 3. Aufl. Huber, Bern
Gomez EA, Comstock BS, Rosario A (1982) Organic versus functional etiology in catatonia: case report. J Clin Psychiatry 43:200–201
Huber G (1955) Zur nosologischen Differenzierung lebensbedrohlicher katatoner Psychosen. Schweiz Arch Neurol Psychiatr 74:216–244
Johnson J (1993) Catatonia: the tension insanity. Br J Psychiatry 162:733–738
Kahlbaum K (1874) Die Katatonie oder das Spannungsirresein. Hirschwald, Berlin
Kral VA (1962) Senescent forgetfullness: benign and malignant. Can Med Ass J 86:257–260
Kratz B, Schröder J, Pantel J, Weimer D, Minnemann E, Lehr O, Sauer H (1998) Leichte kognitive Beeinträchtigung im Alter. Nervenarzt 69:975–982
Lanham JG, Brown MM, Hughes GR (1985) Cerebral systemic lupus erythematosus presenting with catatonia. Postgrad Med J 61:329–330
Lim J, Yagnik P, Schraeder P, Wheeler S (1986) Ictal catatonia as a manifestation of nonconvulsive status epilepticus. J Neurol Neurosurg Psychiatry 49:833–836
Louis ED, Pflaster NL (1995) Catatonia mimicking nonconvulsive status epilepticus. Epilepsia 36:943–945
Mendez MF (1999) Multiple sclerosis presenting as catatonia. Int J Psychiatry Med 29:435–441
Neumärker K-J, Dudeck U, Plaza P (1989) Borrelien-Enzephalitis und Katatonie im Jugendalter. Nervenarzt 60:115–119
Neuman E, Rancurel G, Lecrubier Y, Fohanno D, Boller F (1996) Schizophreniform catatonia on 6 cases secondary to hydrocephalus with subthalamic mesen-cephalic tumor associated with hypodopaminergia. Neuropsychobiology 34:76–81
Orland RM, Daghestani AN (1987) A case of catatonia induced by bacterial meningoencephalitis. J Clin Psychiatry 48:489–490
Patterson JF (1986) Akinetic parkinsonism and the catatonic syndrome: an overview. South Med J 79:682–685
Pichot P, Samuel-Lajeunesse B, Guelfi JD (1969) Problemes etiologiques poses par un syndrome catatonique. Ann Med Psychol (Paris) 1:133–139
Reischies FM (1997). Normales Altern und leichte Demenz. In: Förstl H (Hrsg) Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart, S 366–377
Saß H, Wittchen H-U, Zaudig M (Hrsg) (2000) Diagnostisches und statistisches Manual. psychischer Störungen. DSM-IV, 3. Aufl. Hogrefe, Göttingen, S 209–219
Shah P, Kaplan SL (1980) Catatonic symptoms in a child with epilepsy. Am J Psychiatry 137:738–739
Tippin J, Dunner FJ (1981) Biparietal infarctions in a patient with Catatonia. Am J Psychiatry 138:1386–1387
Walls MJ, Bowers TC, Dilsaver SC, Swann AC (1993) Catatonia associated with depression secondary to complex partial epilepsy. J Clin Psychiatry 54:73
World Health Organization (1993) International Classification of Diseases (ICD10). Chapter V. Diagnostic guidelines. Genf
World Health Organization (1994) International Classification of Diseases (ICD10). Chapter V. Research criteria. Genf
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wetterling, T. (2002). Organische psychische Störungen. In: Organische psychische Störungen. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57532-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-57532-7_4
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63288-4
Online ISBN: 978-3-642-57532-7
eBook Packages: Springer Book Archive